,i #aaith ,,congress #ast ,session ,h4 ,r4 #ebef ,,in ,,the ,,house ,,of ,,representatives ,september #aj1 #bjbe ,mr4 ,carter of ,georgia 7for himself and ,mrs4 ,harshbarger7 introduced the following bill2 which was referred to the ,committee on ,energy and ,commerce1 and in addition to the ,committee on ,ways and ,means1 for a period to be subsequently determined by the ,speaker1 in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned ,a ,,bill ,to amend the ,public ,health ,service ,act to reform the #cdj;,b drug pricing program1 and for other purposes4 #a4 ,short title2 table of contents 7a7 ,short title ,this ,act may be cited as the #cdj;,b ,affording ,care for ,communities and ,ensuring a ,strong ,safety-net ,act or the #cdj;,b ,,access ,act4 7b7 ,table of contents ,the table of contents for this ,act is as follows3 ,sec4 #a4 ,short title2 table of contents4 ,sec4 #b4 ,definitions4 ,sec4 #c4 ,prevention of ,medicaid duplicate discounts2 oversight of covered entities4 ,sec4 #d4 ,hospital child site requirements4 ,sec4 #e4 ,contract pharmacies4 ,sec4 #f4 ,ensuring patient affordability of drugs purchased under section #cdj;,b4 ,sec4 #g4 ,requirements for nonhospital covered entities and subgrantees4 ,sec4 #h4 ,claims modifiers2 covered entity data submission4 ,sec4 #i4 ,covered entity reporting on scope of grant1 contract1 and project4 ,sec4 #aj4 ,ensuring covered entity transparency4 ,sec4 #aa4 ,revisions to existing #cdj;,b hospital eligibility requirements4 ,sec4 #ab4 ,additional requirements for #cdj;,b hospitals4 ,sec4 #ac4 #cdj;,b program4 ,sec4 #ad4 ,audits of private nonhospital contracts with ,state and local governments4 ,sec4 #ae4 ,ensuring covered entity compliance with transparency requirements4 ,sec4 #af4 #cdj;,b claims data clearinghouse4 ,sec4 #ag4 ,limitation on administrator service fees and contract pharmacy fees4 ,sec4 #ah4 ,clarification4 ,sec4 #ai4 ,ensuring the equitable treatment of #cdj;,b covered entities and pharmacies participating in the #cdj;,b drug discount program4 ,sec4 #bj4 ,effective date4 #b4 ,definitions 7a7 ,definition of patient ,section #cdj;,b7b7 of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bef;b7b77 is amended by adding at the end the following3 7#c7 ,patient 7,a7 ,in general ,in this section1 the term patient means1 with respect to a covered entity described in subsection 7a77#d71 an individual who1 on a prescription-by-prescription or order-by-order basis-- 7i7 is dispensed or administered a covered outpatient drug that is-- 7,i7 directly related to the service described in clause 7iii72 7,,ii7 ordered or prescribed by a covered entity provider described in clause 7ii7 as a result of the service described in clause 7iii72 and 7,,iii7 dispensed or administered on site at a covered entity location1 a child site 7as defined in subsection 7a77#e77;,e771 or an entity pharmacy 7as defined in subsection 7a77#e77;,f77 listed in the identification system described in subsection 7d77#b77;,b77iv71 or on site at a contract pharmacy in accordance with subsection 7a77#e77;,f7 or dispensed through a mail order pharmacy in accordance with subsection 7a77#e77;,f72 7ii7 receives the health care service described in clause 7iii7 from a covered entity provider1 meaning a health care professional who either-- 7,i7 is an employee or independent contractor of the covered entity1 such that the covered entity bills for services furnished by the health care professional and is responsible for the care furnished by such professional2 or 7,,ii7 furnishes health care services under an ongoing contractual obligation to the covered entity such that responsibility for the care provided remains with the covered entity and meets the other requirements in this paragraph1 in the event ,state law prohibits or otherwise substantially limits the ability of the covered entity to bill for services of the health care professional2 7iii7 receives a covered outpatient drug in connection with a health care service furnished at the covered entity 7including a child site7 and such drug and service are paid by the insurer or third-party payor as outpatient items and services 7or where third-party reimbursement is not made1 such items and services are deemed outpatient if less than #bd hours have elapsed between such individual's hospital registration and discharge72 7iv7 is described in a category of individuals within the scope of1 and receives a health care service at the covered entity 7including a child site7 that is within the scope of-- 7,i7 the ,federal grant1 project1 or ,federal grant-authorizing statute1 as applicable1 that qualifies such entity for participation in the program under this section1 if the covered entity is described in one of subparagraphs 7,a7 through 7,k7 of subsection 7a77#d72 or 7,,ii7 the contract as required in paragraphs 7#d77,l77i7 and 7#aa7 of subsection 7a71 if the covered entity is a private nonprofit hospital which has1 as the basis for participating in the program under this section1 a contract with a ,state or local government to provide health care services to specified individuals1 provided that clause 7iv7 shall not apply with respect to a covered entity described in subsection 7a77#d77,n7 or a sole community hospital described in subsection 7a77#d77,o72 and 7v7 has an ongoing relationship with the covered entity such that the covered entity creates and maintains auditable health care records which demonstrate compliance with this paragraph and that the covered entity-- 7,i7 has a provider-to-patient relationship with the individual2 7,,ii7 is responsible for the individual's health care service that resulted in the prescription or order for the drug2 and 7,,iii7 7aa7 has provided a health care service to the individual through an in-person visit within the past #ab months1 if the covered entity is a hospital described in subparagraph 7,l7 or subparagraph 7,m7 of subsection 7a77#d7 or is a rural referral center described in subparagraph 7,o7 of such subsection2 or 7bb7 has provided a health care service to the individual through an in-person visit within the past #bd months1 if the covered entity is described in one of subparagraphs 7,a7 through 7,k7 of subsection 7a77#d71 subparagraph 7,n7 of such subsection1 or is a sole community hospital described in subparagraph 7,o7 of such subsection4 7,b7 ,telehealth and telemedicine 7i7 ,in general ,a prescription for a covered outpatient drug resulting from a health care service furnished to an individual through telehealth1 telemedicine1 or other remote health care service arrangements shall not qualify for pricing described in subsection 7a77#a7 unless-- 7,i7 the covered entity 7including child site1 as applicable7 at which such service is furnished is a covered entity 7or a child site of a covered entity1 as applicable7 described in one of subparagraphs 7,a7 through 7,k7 of subsection 7a77#d71 subparagraph 7,n7 of such subsection1 or is a sole community hospital described in subparagraph 7,o7 of such subsection2 and 7,,ii7 subject to the exception in clause 7ii71 a covered entity provider has conducted an in-person examination of the individual within the #f-month time period immediately preceding the health care service resulting in the prescription or order for the drug4 7ii7 ,exception ,the requirement in clause 7i77,,ii7 shall not apply with respect to an individual for whom the covered entity maintains auditable records sufficient to demonstrate that such entity verified such individual is determined eligible for benefits under either title ,,ii of the ,social ,security ,act or title ,,xvi of such ,act in accordance with the provisions of such applicable title4 7,c7 ,prescriptions from non-covered entity providers ineligible 7i7 ,in general ,subject to the exception for care coordination described in clause 7ii71 a covered outpatient drug prescribed or ordered for an individual by a health care professional who is not a covered entity provider shall not qualify for pricing described in subsection 7a77#a74 7ii7 ,exception for care coordination ,in the case of a covered outpatient drug prescribed or ordered for an individual resulting from care coordination provided by the covered entity1 all requirements in subparagraph 7,a7 shall apply1 except for clauses 7i77,i71 7i77,,ii71 7ii71 7iii71 and 7v77,,ii7 of such subparagraph4 ,for purposes of this paragraph1 care coordination shall refer to the sequence of occurrences described in this clause for which a covered entity maintains documentation sufficient to demonstrate that-- 7,i7 a covered entity provider evaluates and recommends to the individual1 during an encounter at the covered entity 7including child site1 as applicable71 that such individual receive a specified type of specialty health care not available at the covered entity and such recommendation is contemporaneously documented1 at the time of such encounter1 in the medical record the covered entity creates and maintains for such individual2 7,,ii7 within one year of the date of the encounter and recommendation described in subclause 7,i71 the individual receives a health care service from a medical specialist of the type described in such recommendation2 7,,iii7 within the time period specified in subclause 7,,ii71 the covered entity provider making the recommendation receives1 directly from the medical specialist that furnishes the health care service described in subclause 7,,ii71 written documentation specifying the service or services furnished to such individual and the diagnoses made in connection with such service or services2 and 7,,iv7 the covered entity retains overall responsibility for the care of the individual4 7iii7 ,covered entity eligibility for care coordination ,notwithstanding any other provision in this section1 a covered entity shall not qualify for pricing described in subsection 7a77#a7 with respect to a prescription or order for a covered outpatient drug resulting from care coordination provided by the covered entity unless such covered entity-- 7,i7 is described in subparagraph 7,n7 of subsection 7a77#d72 7,,ii7 is a sole community hospital described in subparagraph 7,o7 of such subsection2 or 7,,iii7 is described in one of subparagraphs 7,a7 through 7,k7 of such subsection1 is not a specified nonhospital covered entity 7as defined in subsection 7b77#d771 and has a ,federal grant that requires such entity to contract or refer for the health care service or services furnished to the individual by the medical specialist described in clause 7ii74 7,d7 ,health care service required ,for purposes of this section1 an individual shall not be considered a patient of the covered entity described in subsection 7a77#d7 if the individual receives from the covered entity only the administration or infusion of a drug or drugs1 or the dispensing of a drug or drugs for subsequent self-administration or administration in the home setting1 without a covered entity provider-to-patient encounter involving the provision of a health care service4 4 7b7 ,definition of specified nonhospital covered entity ,section #cdj;,b7b7 of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bef;b7b77 is further amended by adding at the end the following3 7#d7 ,specified nonhospital covered entity ,in this section1 the term specified nonhospital covered entity means a covered entity that-- 7,a7 is described in one of subparagraphs 7,b7 through 7,k7 of subsection 7a77#d71 other than a covered entity described in subparagraph 7,g7 of such subsection1 and-- 7i7 has average annual operating revenues exceeding #a1jjj1jjj1jjj calculated over the most recent three-year period for which data are available1 which revenue threshold shall be adjusted for inflation annually to reflect rate of change in the ,consumer ,price ,index for ,all ,urban ,consumers published by the ,bureau of ,labor ,statistics2 or 7ii7 is an affiliate of a hospital2 or 7,b7 is described in subsection 7a77#d77;,a7 and becomes affiliated with a hospital on or after ,december #a1 #bjbd4 ,for purposes of this definition1 the term affiliate shall mean an entity that1 directly or indirectly1 controls1 is controlled by1 or is under common control with the referenced entity1 including the referenced entity's parent1 and the term control shall mean the power to direct the management and policies of an entity1 directly or indirectly1 whether through the ownership of voting securities1 by contract1 or otherwise4 4 #c4 ,prevention of ,medicaid duplicate discounts2 oversight of covered entities ,section #cdj;,b7a77#e7 of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bef;b7a77#e77 is amended-- 7#a7 in subparagraph 7,a7-- 7,a7 in clause 7ii71 by striking ,the ,secretary and inserting ,subject to subsection 7d77#b77;,c71 the ,secretary2 and 7,b7 by adding at the end the following3 7iii7 ,regulations ,not later than #a year after the date of enactment of this clause1 the ,secretary shall promulgate final regulations through notice-and-comment rulemaking describing-- 7,i7 methodologies ,state ,medicaid programs and all covered entities under subsection 7a77#d71 and their contract pharmacies1 shall use to identify and bill drugs purchased under the #cdj;,b program in a manner that ensures compliance with applicable prohibitions regarding duplicate discounts or rebates1 including the duplicate discount prohibition under this subparagraph and the prohibitions under sections #aibg7;j77#a7 and #aijc7m77#b77;,a77xiii7 of the ,social ,security ,act1 to include the application of such prohibitions to #cdj;,b drugs used by ,medicaid managed care enrollees2 and 7,,ii7 procedures ,state ,medicaid programs shall use to exclude requests for ,medicaid rebates on covered outpatient drugs purchased under the #cdj;,b program that are dispensed1 administered1 or otherwise furnished to a ,medicaid managed care enrollee and requirements for ,state ,medicaid programs to promulgate rules to provide affected manufacturers a prompt remedy with respect to any incorrectly billed rebates for such drugs4 2 7#b7 in subparagraph 7,c7-- 7,a7 by striking ,a covered entity shall permit and inserting3 7i7 ,duplicate discounts and drug resale ,a covered entity shall permit 2 7,b7 by striking 7,a7 or 7,b7 and inserting 7,a71 7,b71 7,j71 or 7,k72 and 7,c7 by adding at the end the following3 7ii7 ,use of margin ,a covered entity shall permit the ,secretary to audit1 at the ,secretary's expense1 the records of the entity to determine-- 7,i7 how the margin 7as defined in subparagraph 7,l77iv77 generated on covered outpatient drugs subject to an agreement under this section dispensed or furnished by such entity 7or a contract pharmacy described in subsection 7a77#e77;,f77 is used by such entity2 and 7,,ii7 such entity's compliance with subparagraph 7,l74 7iii7 ,records retention ,covered entities shall retain such records and provide such records and reports as determined necessary by the ,secretary for carrying out this subparagraph4 2 and 7#c7 in subparagraph 7,d71 by striking 7,a7 or 7,b7 and inserting 7,a71 7,b71 7,j71 or 7,k74 #d4 ,hospital child site requirements 7a7 ,hospital child site requirements ,section #cdj;,b7a77#e7 of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bef;b7a77#e77 is amended by adding at the end the following3 7,e7 ,hospital child site requirements 7i7 ,in general ,a covered entity described in one of subparagraphs 7,l7 through 7,o7 of paragraph 7#d7 may register an off-campus outpatient facility associated with such covered entity for inclusion in the identification system described in subsection 7d77#b77;,b77iv7 to participate in the program under this section as an integral part of such covered entity if such covered entity demonstrates to the ,secretary1 in a manner specified by the ,secretary1 that such facility satisfies each of the requirements in this subparagraph4 ,for purposes of this section1 each facility registered to participate in the program under this section and satisfying the requirements in this subparagraph shall be referred to as a child site4 7,i7 ,the facility is listed on the covered entity's most recently filed ,medicare cost report on a line that is reimbursable under the ,medicare program 7or1 if the covered entity is a children's hospital that does not file a ,medicare cost report1 the covered entity submits to the ,secretary a signed statement certifying that the facility would be correctly included on a reimbursable line of a ,medicare cost report if the covered entity filed a cost report74 7,,ii7 ,such cost report demonstrates that the services provided at the facility have associated costs and charges for hospital outpatient department services under title ,,xviii of the ,social ,security ,act 7or1 if the covered entity is a children's hospital that does not file a ,medicare cost report1 the covered entity submits to the ,secretary a signed statement certifying that the services provided at the facility include outpatient services74 7,,iii7 ,the facility is wholly owned by the covered entity4 7,,iv7 ,the ,secretary has made a determination1 under the process described in section #dac4fe7;b7 of title #db1 ,code of ,federal ,regulations 7or any successor regulations71 that the facility meets the ,medicare provider-based standards under section #dac4fe of title #db1 ,code of ,federal ,regulations 7or any successor regulations7 for an off-campus outpatient department of the covered entity4 7,v7 ,the facility provides outpatient health care services that are not limited to only dispensing1 administering1 or otherwise furnishing covered outpatient drugs4 7,,vi7 ,the facility is subject to and adheres to all charity care and sliding fee scale policies of the covered entity and makes such policies publicly available in a manner consistent with requirements established under section #eja7r7 of the ,internal ,revenue ,code of #aihf applicable to hospital financial assistance policies4 7,,vii7 ,the facility is located in an area with a shortage of personal health services that is-- 7aa7 initially designated by the ,secretary pursuant to section #bed;b7b77#c7 of title #db1 ,united ,states ,code1 on or before ,december #a1 #bjbd2 or 7bb7 designated by the ,secretary pursuant to subparagraphs 7,a7 through 7,c7 of section #bed;b7b77#c7 of title #db1 ,united ,states ,code1 after ,december #a1 #bjbd1 using the scoring methodology and criteria specified by the ,secretary as of ,december #a1 #bjbd4 7,,viii7 ,in the case of a covered entity described in one of subparagraphs 7,l7 through 7,o7 of paragraph 7#d7 that is a private nonprofit hospital that has1 as the basis for its participation in the program under this section1 a contract with a ,state or local government to provide health care services to low-income individuals who are uninsured1 as described in paragraphs 7#d77,l77i7 and 7#aa71 the facility independently complies with all requirements applicable to such covered entity with respect to such contract4 7,,ix7 ,for the most recent year1 the facility's total cost incurred for charity care 7as such term is defined in line #bc of worksheet ,s-#aj to the ,medicare cost report1 or in any successor form7 furnished at such facility during such year1 as a share of the facility's total patient service revenue1 is greater than or equal to the amount described in item 7aa7 or item 7bb71 whichever is greater-- 7aa7 for such year1 the total cost incurred for charity care1 as a share of total patient service revenue1 furnished at the covered entity's on-campus locations 7as campus is defined in section #dac4fe7;a77#b7 of title #db1 ,code of ,federal ,regulations 7or any successor regulations772 or 7bb7 the average cost incurred for charity care1 as a share of total patient service revenue1 calculated for the year prior to the most recent year for which data is available1 across all hospitals in the ,state where the facility is located that receive payments for inpatient hospital services under the prospective payment system established under section #ahhf7;d7 of the ,social ,security ,act4 7,x7 ,for the most recent year1 the facility's share of total outpatient services revenue derived from base reimbursement to such entity 7excluding supplemental and indirect reimbursement7 under title ,,xix of the ,social ,security ,act 7including with respect to individuals also entitled to benefits under part ,a of title ,,xviii of such ,act or enrolled in part ,b of title ,,xviii of such ,act7 and payments under title ,,xxi of such ,act for items and services furnished on an outpatient basis at the facility 7including any cost sharing for such items and services7 is greater than or equal to the amount described in item 7aa7 or item 7bb71 whichever is greater-- 7aa7 for such year1 the share of total outpatient services revenue derived from base reimbursement to such entity 7excluding supplemental and indirect reimbursement7 under title ,,xix of the ,social ,security ,act 7including with respect to individuals also entitled to benefits under part ,a of title ,,xviii of such ,act or enrolled in part ,b of title ,,xviii of such ,act7 and payments under title ,,xxi of such ,act for items and services furnished on an outpatient basis at the on-campus locations of the covered entity with which the facility is associated 7including any cost sharing for such items and services7 7campus shall have the meaning given such term in section #dac4fe7;a77#b7 of title #db1 ,code of ,federal ,regulations 7or any successor regulations772 or 7bb7 the average share of total outpatient services revenue derived from base reimbursement 7excluding supplemental and indirect reimbursement7 under title ,,xix of the ,social ,security ,act 7including with respect to individuals also entitled to benefits under part ,a of title ,,xviii of such ,act or enrolled in part ,b of title ,,xviii of such ,act7 and payments under title ,,xxi of such ,act for items and services furnished on an outpatient basis 7including any cost sharing for such items and services71 calculated for the year prior to the most recent year for which data is available1 across all hospitals in the state where the facility is located that receive payments for outpatient hospital services under the prospective payment system for covered outpatient department services established under section #ahcc7t7 of such ,act4 7,,xi7 ,the covered entity certifies1 at the time such facility is initially registered for inclusion in the identification system described in subsection 7d77#b77;,b77iv7 to participate in the drug pricing program under this section and annually thereafter as part of the recertification process1 that the facility satisfies all applicable requirements under this subparagraph4 7ii7 ,limitation ,only an off-campus outpatient facility that meets each of the requirements under this subparagraph may purchase covered outpatient drugs under the #cdj;,b program or use covered outpatient drugs purchased under the #cdj;,b program by another part of the covered entity that is authorized to participate in such program4 ,any transfer of #cdj;,b drugs to another facility or another part of a covered entity that is not authorized to participate in the #cdj;,b program shall be deemed a violation of subparagraph 7,b74 7iii7 ,deregistration ,if at any time following registration a requirement described in clause 7i7 is no longer fully satisfied with respect to a facility1 the covered entity described in such clause shall immediately notify the ,secretary that such facility no longer fully satisfies the relevant requirement1 deregister the facility from the program under this section1 remove the facility from the identification system described in subsection 7d77#b77;,b77iv71 and take all necessary actions to prohibit such facility from making any purchases under the program under this section or representing to third parties that such facility may purchase covered outpatient drugs under such program4 7iv7 ,obligation to self-disclose ,a covered entity described in clause 7i7 shall immediately disclose to the ,secretary and the manufacturer of the affected covered outpatient drug any purchase made under the program under this section by or on behalf of the covered entity with respect to a facility that1 at the time of the purchase of such drug1 did not fully satisfy the requirements in such clause4 ,any such purchase shall require the covered entity to promptly conduct an audit supervised by the ,secretary to identify the full scope of noncompliance with such requirements and to provide the written results of such audit to the ,secretary and the manufacturer of the affected covered outpatient drug4 ,the covered entity shall be liable to the manufacturer of the covered outpatient drug that is the subject of the noncompliance in an amount equal to the reduction in the price of the drugs provided under paragraph 7#a71 plus interest on such amount1 which shall be compounded monthly and equal to the current short-term interest rate as determined by the ,federal ,reserve for the time period for which the covered entity is liable4 7v7 ,civil monetary penalty ,where a covered entity knowingly and intentionally violates clause 7ii7 or otherwise fails to satisfy a requirement in clause 7iii7 or clause 7iv71 the covered entity shall be required to pay a civil monetary penalty equal to #b1ejj for each such violation1 which amount shall be adjusted for inflation annually to reflect the rate of change in the ,consumer ,price ,index for ,all ,urban ,consumers published by the ,bureau of ,labor ,statistics4 ,the provisions of section #aabh;,a of the ,social ,security ,act 7other than subsections 7a7 and 7b77 shall apply to a civil monetary penalty under this clause in the same manner as such provisions apply to a penalty or proceeding under section #aabh;,a7a74 ,the ,office of ,inspector ,general of the ,department of ,health and ,human ,services shall carry out the provisions related to the imposition of civil monetary penalties under this clause4 7vi7 ,secretarial publication of reports ,on an annual basis1 the ,secretary shall prepare and make available to the public in an electronic1 machine readable format separate reports listing facilities that satisfy the requirements in each of subclauses 7,,ix7 and 7,x7 of clause 7i74 4 7b7 ,effective date ,the provisions in section #cdj;,b7a77#e77;,e7 of the ,public ,health ,service ,act1 as added by this ,act1 shall become effective #abj days after the date of enactment of this ,act4 7c7 ,implementation of hospital child site standards ,not later than #fj days prior to the effective date of section #cdj;,b7a77#e77;,e7 of the ,public ,health ,service ,act1 as added by this ,act1 the ,secretary shall issue program instructions directing each covered entity described in section #cdj;,b7a77#e77;,e77i7 of the ,public ,health ,service ,act1 as amended by this ,act1 to1 before the effective date of section #cdj;,b7a77#e77;,e7 of the ,public ,health ,service ,act1 as added by this ,act1 register in the identification system described in section #cdj;,b7d77#b77;,b77iv7 of the ,public ,health ,service ,act1 or update existing registrations in such system for1 off-campus outpatient facilities associated with such covered entity that satisfy the requirements in such section4 ,such instructions shall direct each such covered entity to1 on or before the effective date of section #cdj;,b7a77#e77;,e7 of the ,public ,health ,service ,act1 as added by this ,act1 remove from such system the existing registration of any off-campus outpatient facility associated with such covered entity that does not satisfy the requirements in section #cdj;,b7a77#e77;,e77i7 of the ,public ,health ,service ,act4 ,clauses 7iii7 through 7v7 of section #cdj;,b7a77#e77;,e7 of the ,public ,health ,service ,act shall apply with respect to any covered entity described in one of subparagraphs 7,l7 through 7,o7 of section #cdj;,b7a77#d7 of the ,public ,health ,service ,act that fails to remove a facility described in the immediately preceding sentence on or before the effective date of section #cdj;,b7a77#e77;,e7 of the ,public ,health ,service ,act1 as added by this ,act4 #e4 ,contract pharmacies ,section #cdj;,b7a77#e7 of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bef;b7a77#e77 is further amended by adding at the end the following3 7,f7 ,contract pharmacies 7i7 ,in general ,subject to the conditions set forth in this subparagraph1 a covered entity may enter into written agreements with contract pharmacies to dispense to patients of such entity covered outpatient drugs purchased by such entity under the #cdj;,b program4 ,subject to such conditions1 a manufacturer of covered outpatient drugs shall ship or facilitate shipment of such drugs to contract pharmacies at the request of such covered entity4 ,except with respect to covered outpatient drugs shipped to and dispensed by a contract pharmacy as provided in this subparagraph1 and notwithstanding any other provision in this section1 a manufacturer of covered outpatient drugs shall have no obligation to pay a discount or rebate under this section with respect to covered outpatient drugs delivered or otherwise transferred to any location other than a registered address of the covered entity 7including an entity pharmacy or child site1 as applicable7 listed in the identification system described in subsection 7d77#b77;,b77iv74 7ii7 ,conditions for covered entity use of contract pharmacies ,in order for a covered entity to enter into a written agreement with a contract pharmacy to dispense to patients of such entity covered outpatient drugs purchased by such entity under the program under this section1 the entity shall-- 7,i7 7aa7 be described in one of subparagraphs 7,a7 through 7,k7 of paragraph 7#d7 and purchase covered outpatient drugs for its patients within the scope of the ,federal grant1 project1 or ,federal grant-authorizing statute1 as applicable1 that qualifies such entity for participation in the program under this section2 or 7bb7 be described in one of subparagraphs 7,l7 through 7,o7 of paragraph 7#d72 7,,ii7 establish and implement compliance procedures to satisfy the requirements described in subparagraphs 7,a71 7,b71 7,g7 7as applicable71 7,h7 7as applicable71 7,j71 and 7,k7 of paragraph 7#e7 and section #aaic7;d7 of the ,social ,security ,act with respect to covered outpatient drugs purchased by the covered entity under this section1 including with respect to such drugs dispensed by a contract pharmacy1 which compliance procedures shall be considered records of the covered entity subject to audit under subparagraph 7,c72 7,,iii7 prior to purchasing covered outpatient drugs subject to an agreement under this section to be shipped to or dispensed by such pharmacy1 register such pharmacy in the identification system described in subsection 7d77#b77;,b77iv7 as a contract pharmacy1 to include such pharmacy's national provider identifier1 and certify to the ,secretary upon initial registration of such pharmacy in such system and annually thereafter that such pharmacy complies with all requirements under this subparagraph1 including the covered entity compliance procedures described in subclause 7,,ii72 and 7,,iv7 as applicable1 comply with the requirements and limitations set forth in clauses 7iii7 through 7vii7 of this subparagraph4 7iii7 ,limitation on contract pharmacies for certain hospital covered entities ,notwithstanding clause 7ii71 a covered entity described in paragraph 7#d77,l71 a free-standing cancer hospital described in paragraph 7#d77,m71 and a rural referral center described in paragraph 7#d77,o7 may not enter into written agreements with more than #e contract pharmacies to dispense covered outpatient drugs purchased by the covered entity under this section to patients of such entity under this subparagraph4 ,for purposes of this clause1 a contract pharmacy shall not include a mail order pharmacy4 7iv7 ,service area requirement for eligible contract pharmacies ,a contract pharmacy with which a covered entity enters into a written agreement to dispense covered outpatient drugs to patients of such entity subject to the conditions in this subparagraph shall be located in the service area of the covered entity 7as defined in clause 7x77,,iv774 ,notwithstanding any other provision in this subparagraph1 this clause 7iv7 shall not apply with respect to a covered entity described in paragraph 7#d77;,g7 or a contract pharmacy that is a mail order pharmacy4 7v7 ,requirements for use of mail order pharmacies 7,i7 ,in general ,notwithstanding any other provision in this section1 a covered outpatient drug subject to an agreement under this section may be dispensed to a patient of a covered entity through a mail order pharmacy only if-- 7aa7 the covered entity dispensing such drug 7or on whose behalf such drug is dispensed7 through a mail order pharmacy to such a patient is described in one of subparagraphs 7,a7 through 7,k7 of paragraph 7#d71 such entity is not a specified nonhospital covered entity 7as defined in subsection 7b77#d771 and1 except for a covered entity described in subparagraph 7,g7 of such subsection1 the patient dispensed such drug resides within the service area of the covered entity 7as defined in clause 7x77,,iv772 or 7bb7 the covered entity dispensing such drug 7or on whose behalf such drug is dispensed7 through a mail order pharmacy to such a patient is described in subparagraph 7,n7 of paragraph 7#d7 or is a sole community hospital described in subparagraph 7,o7 of such paragraph1 and the patient dispensed such drug resides in a county that is not part of a ,metropolitan ,statistical ,area1 as defined by the ,office of ,management and ,budget4 7,,ii7 ,requirements for use of mail order contract pharmacies ,subject to the conditions set forth in this subparagraph1 a covered entity described in item 7aa7 or 7bb7 of subclause 7,i7 may enter into written agreements with contract pharmacies that are mail order pharmacies to dispense to patients described in such relevant clause covered outpatient drugs purchased by such entity under the #cdj;,b program4 7vi7 ,requirements for covered entity compliance procedures and written agreements ,not later than #ahj days following the date of enactment of the #cdj;,b ,,access ,act1 the ,secretary shall issue guidance to covered entities specifying requirements for-- 7,i7 covered entity compliance procedures described in clause 7ii77,,ii7 that the ,secretary determines are sufficient to ensure that covered outpatient drugs are not subject to duplicate discounts in violation of subsection 7a77#e77;,a7 7including with respect to such drugs used by ,medicaid managed care enrollees71 that such drugs cannot be resold or otherwise transferred to persons who do not meet the definition of a patient of the covered entity in violation of subparagraph 7,b71 that the patient affordability requirements specified in subparagraphs 7,g7 and 7,h71 as applicable1 are appropriately applied at the point of drug dispense or administration1 that data and other information is submitted in accordance with subparagraphs 7,j7 and 7,k71 and that the nonduplication requirement in section #aaic7;d7 of the ,social ,security ,act is satisfied2 and 7,,ii7 written agreements between covered entities and contract pharmacies described in clause 7vii74 7vii7 ,written agreement required ,the written agreement between a covered entity and a contract pharmacy described in this subparagraph shall include binding and enforceable obligations on the contract pharmacy to comply with the covered entity's compliance procedures described in clause 7ii77,,ii7 with respect to covered outpatient drugs dispensed to patients of such entity in accordance with this subparagraph4 ,within #cj days of the applicable effective date of such written agreement1 including any amendment or addendum thereto1 the covered entity shall submit a copy of the agreement1 together with any amendments or addenda1 to the ,secretary in a form and manner specified by the ,secretary4 ,the ,secretary shall review all such agreements1 including amendments and addenda1 for compliance with the requirements set forth in this subparagraph and may require a covered entity and contract pharmacy to modify an agreement to conform to the requirements of this subparagraph4 ,such agreements1 including amendments and addenda1 shall be considered records of the covered entity subject to audit under subparagraph 7,c74 7viii7 ,clarification for covered outpatient drugs subject to restricted distribution ,notwithstanding any other provision in this section1 a manufacturer of a covered outpatient drug requiring exclusive use of a specialty pharmacy or a restricted distribution network shall be deemed to have satisfied its obligations under this subparagraph with respect to a contract pharmacy if such manufacturer offers each covered entity such drug for purchase at or below the applicable ceiling price described in paragraph 7#a7 through a wholesaler1 distributor1 or pharmacy included in the restricted distribution network for such drug4 7ix7 ,penalties for contract pharmacy compliance violations 7,i7 ,in general ,a contract pharmacy that is found to have violated the covered entity compliance procedures described in clause 7ii77,,ii71 violated subparagraph 7,a71 or violated subparagraph 7,b7 shall-- 7aa7 in the first instance of such violation1 be liable to a manufacturer of a covered outpatient drug that is the subject of such violation in an amount equal to the reduction in the price of such drug 7as described in subsection 7a77#a771 plus interest on such amount1 which shall be compounded monthly and equal to the current short-term interest rate as determined by the ,federal ,reserve for the time period for which the covered entity is liable2 7bb7 in the second instance of such violation-- 7,,aa7 be liable to a manufacturer of a covered outpatient drug that is the subject of such violation in an amount equal to the reduction in the price of the drug 7as described in paragraph 7#a771 plus interest on such amount1 which shall be calculated in the manner specified in item 7aa72 and 7,,bb7 be required to pay a civil monetary penalty equal to #c1jjj for each claim for a covered outpatient drug that is subject to the violation1 which amount shall be adjusted for inflation annually to reflect the rate of change in the ,consumer ,price ,index for ,all ,urban ,consumers published by the ,bureau of ,labor ,statistics2 and 7cc7 in the third instance of such violation-- 7,,aa7 be liable to a manufacturer of a covered outpatient drug that is the subject of such violation in an amount equal to the reduction in the price of the drug 7as described in paragraph 7#a771 plus interest on such amount1 which shall be calculated in the manner specified in item 7aa72 7,,bb7 be required to pay a civil monetary penalty equal to #c1jjj for each claim for a covered outpatient drug that is subject to the violation1 which amount shall be adjusted for inflation annually to reflect the rate of change in the ,consumer ,price ,index for ,all ,urban ,consumers published by the ,bureau of ,labor ,statistics2 and 7,,cc7 be removed from the program under this section and disqualified from reentry into such program for a period of not less than two years1 or such longer period as the ,secretary may determine based on the severity of the violation 7or violations7 and the risk such pharmacy presents to the integrity of the program1 with no ability to reenter the program unless and until the ,secretary determines such pharmacy has resolved the violation 7or violations7 and taken reasonable steps to prevent similar future violations4 7,,ii7 ,corrective action plan ,in the first instance of a violation described in subclause 7,i77aa71 in the second instance of a violation described in subclause 7,i77bb71 and prior to reentry into the program following a violation described in subclause 7,i77cc7-- 7aa7 the pharmacy shall conduct an internal review to identify the cause of the violation 7or violations7 that is inclusive of all calendar quarters within the period in which such violation 7or violations7 occurred and all covered outpatient drugs subject to an agreement under this section dispensed during such period2 7bb7 the pharmacy shall prepare a written corrective action plan1 in a form specified by the ,secretary1 which shall include1 at a minimum1 the results of such internal review1 the pharmacy's methodology for identifying the full scope of such violation 7or violations71 and the pharmacy's proposed corrective actions1 and submit such plan to the ,secretary in a form and manner specified by the ,secretary2 and 7cc7 the ,secretary shall review such plan1 notify the pharmacy of any revisions to such plan1 including additional corrective actions1 necessary for the ,secretary to approve such plan1 and publish the approved plan on a public website of the ,department of ,health and ,human ,services 7with redactions of any confidential or proprietary information74 7,,iii7 ,civil monetary penalty for violations by removed pharmacy ,a contract pharmacy removed from the program under this section pursuant to subclause 7,i77cc7 that dispenses a covered outpatient drug subject to an agreement under this section during a time period that such pharmacy is removed from the program and is not approved for reentry shall be required to pay a civil monetary penalty equal to #c1jjj for each claim for each such drug dispensed during such period1 which amount shall be adjusted for inflation annually to reflect the rate of change in the ,consumer ,price ,index for ,all ,urban ,consumers published by the ,bureau of ,labor ,statistics4 7,,iv7 ,procedures and delegation ,the provisions of section #aabh;,a of the ,social ,security ,act 7other than subsections 7a7 and 7b77 shall apply for purposes of any payment1 civil monetary penalty1 or removal described in this clause in the same manner as such provisions apply to a penalty or proceeding under section #aabh;,a7a74 ,the ,office of ,inspector ,general of the ,department of ,health and ,human ,services shall carry out the provisions of this clause4 7x7 ,definitions ,in this subparagraph3 7,i7 ,contract pharmacy ,the term contract pharmacy means1 with respect to a covered entity described in clause 7ii71 any individual pharmacy 7as determined by a national provider identifier unique to the pharmacy address7 that is-- 7aa7 licensed as a pharmacy by the relevant ,state 7or ,states72 7bb7 authorized to dispense covered outpatient drugs subject to an agreement under this section to patients of such entity 7as defined in subsection 7b77#c77 pursuant to a valid written agreement with such entity 7as described in this subparagraph72 and 7cc7 not an entity pharmacy4 7,,ii7 ,entity pharmacy ,the term entity pharmacy means any individual pharmacy 7as determined by a national provider identifier unique to the pharmacy address7 that is-- 7aa7 7,,aa7 licensed as a pharmacy by the relevant ,state 7or ,states72 and 7,,bb7 the same legal entity as the covered entity and located within the covered entity's service area1 if the covered entity is described in one of subparagraphs 7,a7 through 7,k7 of paragraph 7#d7 and is not a specified nonhospital covered entity 7as defined in subsection 7b77#d772 or 7bb7 the same legal entity as the covered entity and located within the covered entity's four walls1 if the covered entity is described in one of subparagraphs 7,l7 through 7,o7 of paragraph 7#d7 or is a specified nonhospital covered entity 7as defined in subsection 7b77#d774 7,,iii7 ,mail order pharmacy ,the term mail order pharmacy is a pharmacy that is licensed as a pharmacy by the ,state 7or ,states7 and that dispenses prescription medications to individuals primarily through the mail1 as determined in accordance with guidance issued by the ,secretary in connection with part #ddg1 subpart ,i of title #db of the ,code of ,federal ,regulations 7or any successor regulations74 7,,iv7 ,service area ,the term service area means1 with respect to a covered entity described in paragraph 7#d71 other than a covered entity described in subparagraph 7,g7 of such paragraph1 the ,public ,use ,microdata ,area 7as defined by the ,united ,states ,census ,bureau7 in which such entity is located and all ,public ,use ,microdata ,areas that are contiguous with the ,public ,use ,microdata ,area in which such entity is located1 each of which shall be listed in the identification system described in subsection 7d77#b77;,b77iv74 7xi7 ,rules of construction 7,i7 ,location ,for purposes of this subparagraph1 the location of a covered entity shall be determined based on the physical address of the entity listed in the identification system described in subsection 7d77#b77;,b77iv7 without regard to any off-campus outpatient facilities4 7,,ii7 ,same legal entity ,for purposes of this subparagraph1 a pharmacy is the same legal entity as the covered entity if the name1 ownership1 and employer identification number of the pharmacy is identical to the name1 ownership1 and employer identification number of the covered entity4 4 #f4 ,ensuring patient affordability of drugs purchased under section #cdj;,b 7a7 ,in general ,section #cdj;,b7a77#e7 of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bef;b7a77#e77 is further amended by adding at the end the following3 7,g7 ,patient affordability requirements for hospital covered entities 7i7 ,in general ,notwithstanding any other provision of law1 a covered entity described in one of subparagraphs 7,l7 through 7,o7 of paragraph 7#d7 shall establish a sliding fee scale that results in the covered entity providing1 on behalf of an eligible patient 7as defined in clause 7iv771 a discount that results in such patient paying no more than the maximum out-of-pocket obligation 7as defined in clause 7ii771 with respect to each covered outpatient drug subject to an agreement under this section dispensed1 furnished1 or administered to such patient at such covered entity1 any child site1 or any entity pharmacy4 ,the sliding fee scale and related policies shall be written and posted prominently at each such covered entity location1 including any child site and entity pharmacy1 and shall be included in any billing-related communications sent by such covered entity to any patient dispensed1 furnished1 or administered a covered outpatient drug at such covered entity location1 including any child site or entity pharmacy4 ,eligibility for a reduced out-of-pocket obligation pursuant to this clause shall be based on insurance and income information provided by the eligible patient4 ,with respect to covered outpatient drugs that are self-administered by an eligible patient1 the out-of-pocket reductions described in this clause shall apply at the point of sale4 7ii7 ,maximum out-of-pocket obligation ,for each dispense or administration of a covered outpatient drug1 the maximum out-of-pocket obligation for an eligible patient with family income-- 7,i7 below the ,federal poverty guidelines is #j2 7,,ii7 at or above the ,federal poverty guidelines but below #bjj percent of the ,federal poverty guidelines is the lesser of #bj percent of the otherwise applicable out-of-pocket obligation or #ce1 which shall be adjusted for inflation annually to reflect rate of the change in the ,consumer ,price ,index for ,all ,urban ,consumers published by the ,bureau of ,labor ,statistics2 and 7,,iii7 at or above #bjj percent of the ,federal poverty guidelines is the lesser of #cj percent of the otherwise applicable out-of-pocket obligation or #ej1 which shall be adjusted for inflation annually to reflect rate of the change in the ,consumer ,price ,index for ,all ,urban ,consumers published by the ,bureau of ,labor ,statistics4 7iii7 ,applicability to contract pharmacies ,with respect to an eligible patient of a covered entity described in clause 7i7 dispensed a covered outpatient drug subject to an agreement under this section on behalf of such covered entity at a contract pharmacy pursuant to subparagraph 7,f71 such covered entity shall require such contract pharmacy to provide discounts to eligible patients on behalf of such covered entity and comply with all other requirements described in clauses 7i7 and 7ii7 as if such contract pharmacy were a covered entity described in clause 7i74 7iv7 ,definitions ,in this subparagraph3 7,i7 ,child site ,the term child site shall have the meaning given such term in subparagraph 7,e74 7,,ii7 ,contract pharmacy ,the term contract pharmacy shall have the meaning given such term in subparagraph 7,f74 7,,iii7 ,eligible patient ,the term eligible patient means a patient1 as defined in subsection 7b77#c71 who is not covered under minimum essential coverage as defined under section #ejjj;,a7f7 of the ,internal ,revenue ,code of #aihf or has family income below #bjj percent of the ,federal poverty guidelines and is covered under a group health plan1 health insurance coverage in the individual market or group market 7as such terms are defined in section #bgia of the ,public ,health ,service ,act7 or coverage described in section #aef4fjb7;a71 title #de1 ,code of ,federal ,regulations or successor regulation4 7,,iv7 ,entity pharmacy ,the term entity pharmacy shall have the meaning given such term in subparagraph 7,f74 7,v7 ,federal poverty guidelines ,the term ,federal poverty guidelines means the poverty guidelines updated periodically in the ,federal ,register by the ,department of ,health and ,human ,services pursuant to section #iijb7b7 of title #db1 ,united ,states ,code4 7,,vi7 ,out-of-pocket obligation ,the term out-of-pocket obligation means any copayment1 coinsurance1 deductible1 or other cost sharing amount or payment required from an eligible patient in connection with such patient's receipt of a specific health care item or service1 including a covered outpatient drug4 7v7 ,civil monetary penalty ,a covered entity or contract pharmacy that violates a requirement of this subparagraph shall be subject to a civil monetary penalty of #b1ejj for each such violation1 which amount shall be adjusted for inflation annually to reflect the rate of change in the ,consumer ,price ,index for ,all ,urban ,consumers published by the ,bureau of ,labor ,statistics4 ,the provisions of section #aabh;,a of the ,social ,security ,act 7other than subsections 7a7 and 7b77 shall apply to a civil monetary penalty under this clause in the same manner as such provisions apply to a penalty or proceeding under section #aabh;,a7a74 ,the ,office of ,inspector ,general of the ,department of ,health and ,human ,services shall carry out the provisions of this clause4 7vi7 ,regulations ,the ,secretary shall promulgate regulations through notice and comment rulemaking to implement the requirements described in this subparagraph and shall issue final regulations not later than #ij days after the date of enactment of this subparagraph4 ,the authority to promulgate regulations under this clause is limited to specifying the obligations of covered entities and contract pharmacies under this subparagraph and other details necessary to carry out the requirements of this subparagraph efficiently1 effectively1 and in conformity with this subparagraph4 7vii7 ,,oig studies ,the ,office of ,inspector ,general of the ,department of ,health and ,human ,services shall conduct and publish annual studies of covered entity 7including child site and entity pharmacy7 and contract pharmacy practices with respect to the requirements under this subparagraph and evaluate whether eligible patients are receiving assistance to reduce their out-of-pocket obligations in accordance with this subparagraph4 7,h7 ,patient affordability requirements for certain nonhospital covered entities 7i7 ,in general ,notwithstanding any other provision of law1 a covered entity described in one of subparagraphs 7,a7 through 7,k7 of paragraph 7#d7 that is required by the ,federal statute authorizing the grant1 project1 or contract that is the basis for such entity's participation in the program under this section to provide affordability assistance to eligible individuals receiving health care items or services from such entity shall1 with respect to an eligible patient 7as defined in clause 7iii77 dispensed or administered a covered outpatient drug subject to an agreement under this section at a covered entity site1 including an entity pharmacy1 establish a policy that provides a discount to reduce the out-of-pocket obligation of an eligible patient with respect to such drug to an amount sufficient to ensure such patient is not denied access to such drug based on such patient's ability to pay for such drug4 7ii7 ,applicability to contract pharmacies ,with respect to an eligible patient of a covered entity described in clause 7i7 dispensed a covered outpatient drug subject to an agreement under this section on behalf of such covered entity at a contract pharmacy pursuant to subparagraph 7,f71 such covered entity shall require such contract pharmacy to provide discounts to eligible patients on behalf of such covered entity in accordance with the covered entity's policy described in clause 7i74 7iii7 ,definitions ,in this subparagraph3 7,i7 ,contract pharmacy ,the term contract pharmacy shall have the meaning given such term in subparagraph 7,f74 7,,ii7 ,eligible patient ,the term eligible patient means a patient1 as defined in subsection 7b77#c71 who is not covered under minimum essential coverage as defined under section #ejjj;,a7f7 of the ,internal ,revenue ,code of #aihf or has family income below #bjj percent of the ,federal poverty guidelines and is covered under a group health plan1 health insurance coverage in the individual market or group market 7as such terms are defined in section #bgia of the ,public ,health ,service ,act7 or coverage described in section #aef4fjb7;a71 title #de1 ,code of ,federal ,regulations or successor regulation4 7,,iii7 ,entity pharmacy ,the term entity pharmacy shall have the meaning given such term in subparagraph 7,f74 7,,iv7 ,federal poverty guidelines ,the term ,federal poverty guidelines means the poverty guidelines updated periodically in the ,federal ,register by the ,department of ,health and ,human ,services pursuant to section #iijb7b7 of title #db1 ,united ,states ,code4 7,v7 ,out-of-pocket obligation ,the term out-of-pocket obligation means any copayment1 coinsurance1 deductible1 or other cost sharing amount or payment required from an eligible patient in connection with such patient's receipt of a specific health care item or service1 including a covered outpatient drug4 4 #g4 ,requirements for nonhospital covered entities and subgrantees ,section #cdj;,b7a77#e7 of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bef;b7a77#e77 is further amended by adding at the end the following3 7,i7 ,additional requirements for nonhospital covered entities2 requirements for subgrantees 7i7 ,additional requirements for nonhospital covered entities ,a covered entity described in one of subparagraphs 7,a7 through 7,k7 of paragraph 7#d7 shall1 as a condition of participation in the program under this section-- 7,i7 be a nonprofit or public entity 7as determined by the ,secretary72 7,,ii7 be eligible to purchase a covered outpatient drug subject to an agreement under this section only with respect to a patient receiving a health care service at a registered covered entity site1 and such service and such drug are within the scope and time period of the ,federal grant1 project1 or ,federal grant-authorizing statute1 as applicable1 that qualifies such covered entity for participation in the program under this section2 7,,iii7 oversee the participation in the program under this section of any subgrantee with which such covered entity enters into an enforceable written agreement in accordance with subclause 7,,iv7 and be directly liable for noncompliance by any such subgrantee with any requirement under this section2 7,,iv7 have an enforceable written agreement with any subgrantee1 which shall apply to all registered sites of such subgrantee1 and require such subgrantee to comply with all requirements under this section otherwise applicable to the covered entity and to maintain written records1 which shall be made available to the ,secretary upon request1 sufficient to demonstrate such subgrantee's receipt of eligible ,federal funds or an in-kind contribution purchased with such funds1 as described in clause 7iii71 and the grant under which such subgrantee receives such funds or contribution2 and 7,v7 maintain written records sufficient to demonstrate such entity authorized such subgrantee to1 prior to purchasing covered outpatient drugs subject to an agreement under this section1 register each subgrantee site in the covered entity identification system established under subsection 7d77#b77;,b77iv7 to participate in the program under this section as a subgrantee of such entity and provide the ,secretary with such registration information as requested to demonstrate such subgrantee's receipt of eligible ,federal funds or an in-kind contribution purchased with such funds1 as described in clause 7iii71 and the grant under which the subgrantee receives such funds or contribution4 7ii7 ,requirements for subgrantees ,notwithstanding any other provision in this section1 a subrecipient of a ,federal grant shall be eligible to participate in the program under this section only if such subrecipient is a subgrantee 7as defined in clause 7iii77 and such subgrantee-- 7,i7 is a nonprofit or public entity 7as determined by the ,secretary72 7,,ii7 prior to purchasing covered outpatient drugs subject to an agreement under this section-- 7aa7 enters into an enforceable written agreement with the covered entity providing eligible ,federal funds or an in-kind contribution1 pursuant to clause 7i77,,iv72 7bb7 maintains written records1 which shall be made available to the ,secretary upon request1 sufficient to demonstrate such subgrantee's receipt of eligible ,federal funds or an in-kind contribution purchased with such funds1 as described in clause 7iii71 and the grant under which such subgrantee receives such funds or contribution2 and 7cc7 registers each subgrantee site to participate in the program under this section in the covered entity identification system established under subsection 7d77#b77;,b77iv72 7,,iii7 purchases covered outpatient drugs subject to an agreement under this section only with respect to a patient receiving a health care service at a registered subgrantee site1 and such service and such drug are within the scope and time period of the ,federal grant1 project1 or grant-authorizing statute1 as applicable1 that qualifies such subgrantee for participation in the program under this section2 7,,iv7 in the case of a subgrantee that receives an in-kind contribution from a covered entity described in paragraph 7#d77,k71 demonstrates to such covered entity and to the ,secretary1 upon initial registration to participate in the program under this section and on an annual basis thereafter1 that the number of individuals aged #ai to #fd years receiving a health care service at the registered subgrantee site during the most recent calendar year who are enrolled under a ,state plan under title ,,xix of the ,social ,security ,act 7or a waiver of such plan71 as a share of all individuals aged #ai to #fd years receiving a health care service at the registered subgrantee site during such calendar year1 exceeds the number of individuals aged #ai to #fd years who reside in the ,state where such subgrantee site is located and are enrolled under a ,state plan under title ,,xix of such ,act 7or a waiver of such plan71 as a share of all individuals aged #ai to #fd who reside in such ,state1 each as measured by data available from the ,american ,community ,survey of the ,bureau of the ,census for the calendar year preceding the most recent calendar year2 7,v7 in the case of a subgrantee that receives an in-kind contribution from a covered entity described in paragraph 7#d77,k71 submits to such covered entity and to the ,secretary1 upon receipt of each in-kind contribution described in clause 7iii7-- 7aa7 a written plan in a form specified by the ,secretary describing how such contribution will be used to further the goals of the relevant ,federal grant1 how such subgrantee will ensure that purchases of covered outpatient drugs under the program under this section are consistent with the goals of such grant1 and how such subgrantee will ensure compliance with the requirements under subparagraph 7,a7 and 7,b72 and 7bb7 a written plan in a form specified by the ,secretary and using criteria established by the ,secretary to determine the date upon which its eligibility to participate in the program under this section1 as a result of such contribution1 shall terminate 7absent such subgrantee's receipt of additional funds or contributions described in clause 7iii772 7,,vi7 subject to subclause 7,,vii71 immediately notifies the ,secretary1 disenrolls from the program under this section1 and discontinues making purchases under such program and representing to third parties that it may purchase under such program as of the date described in subclause 7,v77bb7 or if1 at any time during its participation in the program under this section1 it no longer meets one or more applicable requirements under this section2 and 7,,vii7 not later than #cj days following the date on which the covered entity with which such subgrantee has an agreement pursuant to clause 7i7 ceases participation in the program under this section1 such subgrantee either-- 7aa7 disenrolls from the program under this section and discontinues making purchases under such program and representing to third parties that such subgrantee may purchase under such program2 or 7bb7 enters into an enforceable written agreement with a different covered entity described in one of subparagraphs 7,a7 through 7,k7 of paragraph 7#d7 that is participating in the program under this section1 and satisfies all applicable requirements under this section with respect to such different covered entity4 7iii7 ,subgrantee defined 7,i7 ,in general ,in this subparagraph1 the term subgrantee means a subrecipient of a ,federal grant that-- 7aa7 receives eligible ,federal funds from a covered entity described in one of subparagraphs 7,a7 through 7,k7 of paragraph 7#d7 in the form of nonnominal and ongoing payments by such covered entity directly to such subrecipient to directly support the provision of health care services by such subrecipient to individuals within the scope and time period of the ,federal grant1 project1 or ,federal grant-authorizing statute1 as applicable1 that qualifies such covered entity for participation in the program under this section2 or 7bb7 receives in-kind contributions from a covered entity described in paragraph 7#d77,k7 and such contributions-- 7,,aa7 are ongoing and are in the form of real property1 equipment1 supplies1 or services2 7,,bb7 subject to subclause 7,,ii71 have a value exceeding #be1jjj per year1 which shall be adjusted for inflation annually to reflect the rate of change in the ,consumer ,price ,index for ,all ,urban ,consumers published by the ,bureau of ,labor ,statistics and determined by the subrecipient and approved by the covered entity providing such contribution in a manner specified by the ,secretary2 7,,cc7 are specifically identifiable and provided by such covered entity directly to such subrecipient2 and 7,,dd7 directly support the provision of health care items and services by such subrecipient solely to individuals within the scope and time period of the ,federal grant that qualifies such covered entity for participation in the program under this section4 7,,ii7 ,exclusion ,the requirement specified in subclause 7,i77bb77,,bb7 shall not apply with respect to a subrecipient of a ,federal grant that receives in-kind contributions from a covered entity described in paragraph 7#d77,k7 if-- 7aa7 as of ,january #a1 #bjbe1 such subrecipient is participating in the program under this section as such a subrecipient and is in compliance with all requirements under this section otherwise applicable to such subrecipient2 and 7bb7 with respect to any in-kind contribution such subrecipient receives after ,january #a1 #bjbe1 such subrecipient has continuously participated in the program under this section as such a subrecipient in compliance with all requirements under this section for the period beginning on ,january #a1 #bjbe1 and continuing through the date on which program participation ends as determined in the plan submitted to the ,secretary pursuant to clause 7ii77,v77bb7 or any such earlier date on which program participation ends4 7iv7 ,rule of construction ,for purposes of this section1 any subgrantee that is not itself a covered entity described in one of subparagraphs 7,a7 through 7,k7 of paragraph 7#d7 shall be subject to the obligations under this section applicable to the covered entity with which such subgrantee has an enforceable written agreement pursuant to clause 7i74 ,further1 for purposes of this section1 each registered site of such subgrantee shall be subject to the requirements set forth in subparagraph 7,f7 as if such site were the covered entity with which such subgrantee has an enforceable written agreement pursuant to clause 7i74 4 #h4 ,claims modifiers2 covered entity data submission ,section #cdj;,b7a77#e7 of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bef;b7a77#e77 is further amended by adding at the end the following3 7,j7 ,claims modifier and covered entity data submission 7i7 ,claims modifier ,all claims submitted to a payor1 including1 without limitation1 ,medicare and ,medicaid1 by a covered entity or a contract pharmacy under a contract with a covered entity in compliance with subparagraph 7,f7 for reimbursement of a unit of a covered outpatient drug purchased under the program under this section shall include the relevant #cdj;,b modifier established by the ,secretary under ,medicare ,part ,b 7that is ,,jg1 ,,tb1 or any successor modifier7 or the ,submission ,clarification ,code of #bj or any successor modifier developed by the ,national ,council for ,prescription ,drug ,programs 7,,ncpdp7 to identify claims for covered outpatient drugs purchased under such program4 ,all claims submitted by a covered entity or a contract pharmacy described in this clause to a payor1 including1 without limitation1 ,medicare and ,medicaid1 for reimbursement of a unit of a covered outpatient drug not purchased under such program shall also include a relevant non-#cdj;,b modifier1 which shall be established by the ,secretary1 or a non-#cdj;,b modifier developed by the ,,ncpcp to identify such claims4 7ii7 ,covered entity data submission ,a covered entity described in paragraph 7#d7 shall 7and shall cause any entity acting on its behalf to7 furnish to the clearinghouse described in subsection 7d77#b77;,c7 the data described in clause 7iii71 in a machine-readable format1 with respect to each covered outpatient drug dispensed1 furnished1 or administered by the covered entity 7including such drugs dispensed by a contract pharmacy under contract with such covered entity in compliance with subparagraph 7,f771 for which such covered entity seeks or has received discounted pricing under this section4 ,such covered entity shall provide1 or cause to be provided1 such data to the clearinghouse within #de days after the date on which the covered outpatient drug was dispensed1 furnished1 or administered 7or such shorter time period as may be specified by the ,secretary through notice-and-comment rulemaking7 in an electronic format specified by the ,secretary4 ,the covered entity shall require 7and shall cause any entity acting on its behalf to require7 that data on pharmacy-dispensed drugs described in this subparagraph be submitted to the clearinghouse directly by the pharmacy dispensing such drug4 7iii7 ,claim level data elements ,the data described in this clause shall include the following1 as applicable3 7,i7 ,self-administered drugs ,with respect to a self-administered drug dispensed at a pharmacy1 by a mail order service1 or by another dispenser-- 7aa7 prescription number2 7bb7 prescribed date2 7cc7 prescription fill date2 7dd7 national drug code 7,,ndc7 of the drug2 7ee7 quantity dispensed2 7ff7 bank identification number1 processor control number1 and group number of the plan receiving the claim 7as applicable72 7gg7 national provider identifier 7,,npi7 of the prescriber2 7hh7 ,,npi of the dispensing pharmacy2 7ii7 name and #cdj;,b identifier of the covered entity dispensing the drug1 or on whose behalf the drug is dispensed2 7jj7 #cdj;,b_/non-#cdj;,b claim modifier2 7kk7 wholesaler invoice number2 and 7ll7 an indicator1 which shall be specified by the clearinghouse or the ,secretary1 denoting that the drug was or was not dispensed as a result of care coordination described in subsection 7b77#c74 7,,ii7 ,provider-administered drugs ,with respect to a drug furnished or administered by a physician or other provider of services or a supplier-- 7aa7 drug billing and payment code_/,,hcpcs code2 7bb7 ,,ndc of the drug2 7cc7 claim number2 7dd7 ,medicare provider number of prescriber 7as applicable72 7ee7 ,,npi of the prescriber2 7ff7 name and #cdj;,b identifier of the covered entity furnishing or administering the drug2 7gg7 date drug furnished or administered2 7hh7 claim adjudication date2 7ii7 quantity furnished or administered2 7jj7 #cdj;,b_/non-#cdj;,b claim modifier2 and 7kk7 an indicator1 which shall be specified by the clearinghouse or the ,secretary1 denoting that the drug was or was not furnished or administered as a result of care coordination described in subsection 7b77#c74 7iv7 ,information privacy and security ,a covered entity described in paragraph 7#d7 shall provide the data specified in clause 7iii7 to the clearinghouse in a secure manner1 consistent with such entity's obligations under the ,security ,standards for the ,protection of ,electronic ,protected ,health ,information described in part #afd of subpart ,c of title #de1 ,code of ,federal ,regulations 7or any successor regulations74 ,a covered entity shall not be required to obtain an individual authorization under part #afd of subpart ,e of title #de1 ,code of ,federal ,regulations 7or any successor regulations7 for its reporting of such data to the clearinghouse4 7v7 ,standardization of reported data elements2 prohibition on modifications ,a covered entity described in paragraph 7#d7 shall take reasonable steps to ensure the data specified in clause 7iii7 submitted to the clearinghouse fully complies with the data submission standards 7including field descriptors and definitions7 specified by the clearinghouse or the ,secretary following consultation with relevant stakeholders1 including manufacturers of covered outpatient drugs4 ,a covered entity described in paragraph 7#d7 is prohibited1 and shall prohibit any entity acting on its behalf 7including any affiliate of such entity71 from taking or refraining from taking any action that would cause such information to no longer comply with the standards described in this clause4 ,in specifying the data submission standards described in this clause1 the clearinghouse and the ,secretary1 as applicable1 shall seek to minimize administrative burden on covered entities while ensuring such data satisfies the intent of this subparagraph4 7vi7 ,covered entities that fail to report ,a covered entity that fails to furnish the information as required under this subparagraph shall be subject to a civil monetary penalty in the amount of #b1ejj for each day of such violation1 which amount shall be adjusted for inflation annually to reflect the rate of change in the ,consumer ,price ,index for ,all ,urban ,consumers published by the ,bureau of ,labor ,statistics4 ,the provisions of section #aabh;,a of the ,social ,security ,act 7other than subsections 7a7 and 7b77 shall apply to a civil monetary penalty under this clause in the same manner as such provisions apply to a penalty or proceeding under section #aabh;,a7a74 ,the ,office of ,inspector ,general of the ,department of ,health and ,human ,services shall carry out the provisions of this clause4 4 #i4 ,covered entity reporting on scope of grant1 contract1 and project ,section #cdj;,b7a77#e7 of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bef;b7a77#e77 is further amended by adding at the end the following3 7,k7 ,reporting on scope of grant1 contract1 and project ,a covered entity described in one of subparagraphs 7,a7 through 7,k7 of paragraph 7#d7 shall submit information specified by the ,secretary to the identification system described in subsection 7d77#b77;,b77iv7 at least annually1 in a form and manner specified by the ,secretary1 describing the scope of its ,federal grant or project1 or the ,federal grant-authorizing statute1 as applicable1 that is the basis for such entity's eligibility for the program under this section4 ,such information shall include copies of agreements between such entity and any subgrantee1 as described in subparagraph 7,i74 ,access to information described in this subparagraph shall be made available to a manufacturer of a covered outpatient drug1 upon request1 in a manner specified by the ,secretary4 4 #aj4 ,ensuring covered entity transparency 7a7 ,in general ,section #cdj;,b7a77#e7 of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bef;b7a77#e77 is further amended by adding at the end the following3 7,l7 ,reporting 7i7 ,in general ,during the first year beginning on or after the date that is #ad months after the date of enactment of this subparagraph and during each subsequent year1 each covered entity described in subparagraph 7,l7 of paragraph 7#d7 7and any other covered entity specified by the ,secretary7 shall report to the ,secretary 7at a time and in a form and manner specified by the ,secretary7 the following information with respect to the preceding year3 7,i7 ,with respect to such covered entity and each child site1 as applicable1 of such entity-- 7aa7 the total number of individuals who were dispensed or administered covered outpatient drugs during such preceding year that were subject to an agreement under this section2 and 7bb7 the number of such individuals described in a category specified in clause 7iii71 broken down by each such category4 7,,ii7 ,with respect to such covered entity and each child site1 as applicable1 of such entity-- 7aa7 the percentage of the total number of individuals furnished items and services during such preceding year who were dispensed or administered covered outpatient drugs during such preceding year that were subject to an agreement under this section2 and 7bb7 for each category specified in clause 7iii71 the percentage of the total number of individuals described in such category furnished items and services during such preceding year who were dispensed or administered covered outpatient drugs during such preceding year that were subject to an agreement under this section4 7,,iii7 ,with respect to such covered entity and each child site1 as applicable1 of such entity1 the total costs incurred during the year at each such site and the cost incurred at each such site for charity care 7as defined in line #bc of worksheet ,s-#aj to the ,medicare cost report1 or in any successor form74 7,,iv7 ,with respect to such covered entity and each child site1 as applicable1 of such entity1 the costs incurred during the year of furnishing items and services at each such entity or site to patients of such entity who were entitled to benefits under part ,a of title ,,xviii of the ,social ,security ,act or enrolled under part ,b of such title1 enrolled in a ,state plan under title ,,xix of such ,act 7or a waiver of such plan71 or who were uninsured for services1 minus the sum of-- 7aa7 payments under title ,,xviii of such ,act for such items and services 7including any cost sharing for such items and services72 7bb7 payments under title ,,xix of such ,act for such items and services 7including any cost sharing for such items and services72 and 7cc7 payments by uninsured patients for such items and services4 7,v7 ,with respect to such covered entity and each child site1 as applicable1 of such entity1 the margin 7as defined in clause 7iv77 generated on covered outpatient drugs subject to an agreement under this section dispensed or furnished by such entity or site 7and any entity pharmacy or contract pharmacy dispensing such drugs on behalf of such entity in accordance with subparagraph 7,f771 with each component of the margin calculation described in item 7aa7 through 7cc7 of such clause listed as a separate line item4 7,,vi7 ,to the extent the ,secretary requires covered entities described in one of subparagraphs 7,a7 through 7,k7 of paragraph 7#d7 to report information pursuant to this subparagraph1 with respect to each such covered entity1 use of margin 7as defined in clause 7iv77 generated on covered outpatient drugs subject to an agreement under this section in the following categories of expenditures1 if applicable1 which the ,secretary shall define in interim final regulations in a manner consistent with reporting under the ,health ,resources and ,services ,administration ,uniform ,data ,system 7,,uds7-- 7aa7 medical care2 7bb7 dental care2 7cc7 mental health2 7dd7 pharmaceuticals1 which shall include margin used to provide free and discounted covered outpatient drugs subject to an agreement under this section dispensed or furnished to eligible patients 7as defined in subparagraph 7,h771 notwithstanding any ,,uds reporting requirement that may limit or interfere with the inclusion of margin used for such purpose2 7ee7 sliding fee discounts2 7ff7 case management2 7gg7 transportation2 7hh7 patient and community education2 7ii7 community health workers2 7jj7 outreach2 7kk7 eligibility assistance2 and 7ll7 nutritional assessment and referral4 7ii7 ,publication ,the ,secretary shall publish data reported under clause 7i7 with respect to a year annually on the public website of the ,department of ,health and ,human ,services in an electronic and searchable format1 which may include the #cdj;,b ,office of ,pharmacy ,affairs ,information ,system 7or a successor to such system71 in a manner that shows each category of data reported in the aggregate and identified by the specific covered entity submitting such data4 ,the ,secretary shall include in such publication the disproportionate patient percentage 7as defined in section #ahhf7;d77#e77;,f77vi7 of the ,social ,security ,act7 of each such covered entity 7if applicable7 for each cost reporting period occurring during such year4 7iii7 ,categories specified ,for purposes of clause 7i71 the categories specified in this clause are the following3 7,i7 ,individuals covered under a group health plan or group or individual health insurance coverage 7as such terms are defined in section #bgia74 7,,ii7 ,individuals entitled to benefits under part ,a or enrolled under part ,b of title ,,xviii of the ,social ,security ,act4 7,,iii7 ,individuals enrolled under a ,state plan under title ,,xix of such ,act 7or a waiver of such plan74 7,,iv7 ,individuals enrolled under a ,state child health plan under title ,,xxi of such ,act 7or a waiver of such plan74 7,v7 ,individuals not described in any preceding subclause and not covered under any ,federal health care program 7as defined in section #aabh;,b of such ,act but including the program established under chapter #hi of title #e1 ,united ,states ,code74 7iv7 ,definitions ,in this subparagraph3 7,i7 ,child site ,the term child site shall have the meaning given such term in subparagraph 7,e74 7,,ii7 ,entity pharmacy ,the term entity pharmacy shall have the meaning given such term in subparagraph 7,f74 7,,iii7 ,margin ,the term margin means1 with respect to covered outpatient drugs purchased by a covered entity under an agreement under this section1 the following amount for such drugs dispensed1 furnished1 or administered to an individual by such entity or a child site of such entity 7and any entity pharmacy or contract pharmacy dispensing such drugs on behalf of such entity in accordance with subparagraph 7,f77-- 7aa7 aggregate payments received by the covered entity for such drugs from individuals 7including cost-sharing amounts7 and third parties1 including government and private payors2 7bb7 aggregate costs to acquire such drugs at either the ceiling price described in paragraph 7#a7 or any voluntary subceiling price at which the covered entity purchased such drug or drugs1 as applicable2 minus 7cc7 aggregate costs incurred by the covered entity that are necessary for such entity to participate in the program under this section and to comply with such program's requirements1 including program-related compliance1 legal1 educational1 and administrative costs 7such costs shall be determined in accordance with ,generally ,accepted ,accounting ,principles71 and compensation paid to third-party administrators or contract pharmacies to carry out program-related functions4 4 7b7 ,rulemaking ,not later than #ahj days after the date of enactment of this ,act1 the ,secretary of ,health and ,human ,services shall issue an interim final rule to carry out section #cdj;,b7a77#e77,l7 of the ,public ,health ,service ,act1 as added by subsection 7a74 #aa4 ,revisions to existing #cdj;,b hospital eligibility requirements ,section #cdj;,b7a77#d7 of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bef;b7a77#d77 is amended-- 7#a7 in subparagraph 7,l77i7-- 7,a7 by inserting and that was registered with the #cdj;,b program in the covered entity identification system established under subsection 7d77#b77;,b77iv7 as such a hospital on or before ,december #a1 #bjbd after formally granted governmental powers by a unit of state or local government2 and 7,b7 by striking not entitled to benefits under title ,,xviii of the ,social ,security ,act and all that follows up to the semicolon at the end and inserting uninsured1 as such terms are defined in subsection 7a77#aa72 7#b7 by amending subparagraph 7,n7 to read as follows3 7,n7 ,an entity that is a critical access hospital 7as determined under section #ahbj7;c77#b7 of the ,social ,security ,act 7#db ,u4,s4,c4 #acie;i-#d7;c77#b777 or a rural emergency hospital 7as determined under the requirements in section #ahfa7kkk7 of the ,social ,security ,act 7#db ,u4,s4,c4 #aciex7kkk7 and in implementing regulations set forth in parts #dai1 #dbd1 #dhe1 #dhh1 and #dhi of title #db of the ,code of ,federal ,regulations in effect as of ,january #a1 #bjbd771 and that meets the requirements of subparagraph 7,l77i74 2 and 7#c7 in subparagraph 7,o7 by inserting that demonstrates to the ,secretary that at least #fj percent of annual inpatient discharges for cost reporting periods beginning after ,december #a1 #bjbd1 are for inpatients who reside in a county that is not part of a ,metropolitan ,statistical ,area1 as defined by the ,director of the ,office of ,management and ,budget before 1 or a sole community hospital4 #ab4 ,additional requirements for #cdj;,b hospitals ,section #cdj;,b7a7 of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bef;b7a77 is amended by adding at the end the following3 7#aa7 ,clarification of eligibility standards for private nonprofit hospitals with a contract with a ,state or local government to provide health care services 7,a7 ,contract requirements ,for purposes of paragraph 7#d77,l77i7 and cross-references to subparagraph 7,l7 or clause 7i7 of such paragraph appearing in subparagraph 7,m7 and subparagraph 7,o7 of such paragraph with respect to a rural referral center1 a private nonprofit hospital has a contract with a ,state or local government to provide health care services to low-income individuals who are uninsured if-- 7i7 the hospital submits a copy of the contract 7including any appendices or addenda or subsequent amendments7 to the ,secretary for review2 7ii7 the ,secretary determines that the contract creates an enforceable obligation for the hospital to provide direct medical care to low-income individuals who are uninsured in an amount that represents at least #aj percent of the hospital's total costs of care2 7iii7 the ,secretary further determines1 based on a review of the contract 7as described in clause 7i77 that the contract creates an enforceable obligation for the hospital to furnish the individuals described in clause 7ii7 the full range of services provided at the hospital 7including any child sites72 and 7iv7 the contract 7as described in clause 7i77 is available to the public as part of the information describing the hospital in the covered entity identification system established under subsection 7d77#b77;,b77iv74 7,b7 ,deregistration ,if at any time a hospital not owned or operated by a unit of ,state or local government that has been participating in the program under this section on the basis of having a contract with a ,state or local government to provide health care services that is subject to subparagraph 7,a7 no longer satisfies a requirement under such subparagraph1 the hospital shall immediately notify the ,secretary that the hospital no longer satisfies the relevant requirement1 deregister the hospital from the program under this section and the identification system described in subsection 7d77#b77;,b77iv71 and cease making purchases under such program and representing to third parties that it may purchase under such program4 7,c7 ,obligation to self-disclose ,a covered entity described in subparagraph 7,b7 shall immediately disclose to the ,secretary and the manufacturer of the affected covered outpatient drug any purchase made under the program under this section by such covered entity that1 at the time of the purchase of such drug1 did not fully satisfy the requirements in subparagraph 7,a74 ,any such purchase shall require the covered entity to promptly conduct an audit supervised by the ,secretary to identify the full scope of noncompliance with such requirements and to provide the written results of such audit to the ,secretary and the manufacturer of the affected covered outpatient drug4 ,the covered entity shall be liable to the manufacturer of the covered outpatient drug that is the subject of the noncompliance in an amount equal to the reduction in the price of the drugs provided under subsection 7a77#a71 plus interest on such amount1 which shall be compounded monthly and equal to the current short-term interest rate as determined by the ,federal ,reserve for the time period for which the covered entity is liable4 7,d7 ,civil monetary penalty ,where a covered entity fails to satisfy a requirement in subparagraph 7,b7 or 7,c71 the covered entity shall be required to pay a civil monetary penalty equal to #b1ejj for each violation1 which amount shall be adjusted for inflation annually to reflect the rate of change in the ,consumer ,price ,index for ,all ,urban ,consumers published by the ,bureau of ,labor ,statistics4 ,the provisions of section #aabh;,a of the ,social ,security ,act 7other than subsections 7a7 and 7b77 shall apply to a civil monetary penalty under this subparagraph in the same manner as such provisions apply to a penalty or proceeding under section #aabh;,a7a74 ,the ,office of ,inspector ,general of the ,department of ,health and ,human ,services shall carry out the provisions related to the imposition of civil monetary penalties under this subparagraph4 7,e7 ,definitions ,in this paragraph3 7i7 ,federal poverty guidelines ,the term ,federal poverty guidelines means the poverty guidelines updated periodically in the ,federal ,register by the ,department of ,health and ,human ,services pursuant to section #iijb7b7 of title #db1 ,united ,states ,code4 7ii7 ,low-income individual ,the term low-income individual means an individual with family income at or below #bjj percent of the ,federal poverty guidelines4 7iii7 ,uninsured ,the term uninsured means lacking minimum essential coverage1 as defined in subsection #ejjj;,a7f7 of the ,internal ,revenue ,code 7#bf ,u4,s4,c4 #ejjj;,a7f77 and implementing regulations4 7#ab7 ,additional requirement for private nonprofit disproportionate share hospitals located in urban areas 7,a7 ,in general ,a covered entity described in paragraph 7#d77,l77i7 that is either a private nonprofit hospital that has as the basis for its participation in the program under this section a contract with a ,state or local government as described in such paragraph and in paragraph 7#aa71 or that is a private nonprofit corporation which is formally granted governmental powers by a unit of ,state or local government1 and such entity is located in a county that is part of a ,metropolitan ,statistical ,area1 as defined by the ,office of ,management and ,budget1 must1 for the preceding year1 fall within the top #dj percent of hospitals on each of the lists described in subparagraphs 7,b7 and 7,c7 prepared by the ,secretary with respect to the ,state in which the covered entity is located4 ,as described further in subparagraph 7,d71 placement in the top #dj percent of hospitals on both of such lists is a condition of such covered entity's participation in the program under this section and failure to meet this condition shall require deregistration and self-disclosure using the procedures described in subparagraphs 7,b7 and 7,c7 of paragraph 7#aa74 ,such covered entity shall be subject to a civil monetary penalty described in paragraph 7#aa77;,d7 for failure to deregister and self-disclose in accordance with the preceding sentence4 7,b7 ,medicaid and ,,chip outpatient revenue ,within #ij days following the conclusion of a year1 the ,secretary shall prepare and make available to the public in an electronic1 machine-readable format for each ,state for the concluded year1 a list that ranks all acute care hospitals in such ,state in descending order based on each hospital's share of total outpatient services revenue derived from base reimbursement to such hospital 7excluding supplemental and indirect reimbursement7 under title ,,xix of the ,social ,security ,act 7including with respect to individuals also entitled to benefits under part ,a of title ,,xviii of such ,act or enrolled in part ,b of title ,,xviii of such ,act7 and payments under title ,,xxi of such ,act for items and services furnished on an outpatient basis at the hospital 7including any cost sharing for such items and services74 ,the ,secretary shall specify the threshold for the top #dj percent of hospitals on the list4 7,c7 ,uncompensated outpatient care ,within #ij days following the conclusion of a year1 the ,secretary shall prepare and make available to the public in an electronic1 machine-readable format for each ,state for the concluded year1 a list that ranks all acute care hospitals in such ,state in descending order based on each hospital's total cost of uncompensated care for items and services furnished on an outpatient basis as a share of the hospital's total outpatient services revenue4 ,for purposes of this list1 costs of uncompensated outpatient care shall be determined in a manner consistent with the instructions on worksheet ,s-#aj to the ,medicare cost report 7or any successor form71 with adjustments to limit uncompensated outpatient care costs to those incurred in providing items and services on an outpatient basis at the hospital4 ,the ,secretary shall specify the threshold for the top #dj percent of hospitals on the list4 7,d7 ,deregistration ,within #cj days following the ,secretary's publication of the lists described in subparagraphs 7,b7 and 7,c71 each covered entity subject to this paragraph that is not included in the top #dj percent of hospitals on both lists shall notify the ,secretary that the covered entity does not satisfy one or more requirements described in this paragraph1 deregister the entity from the program under this section and the identification system described in subsection 7d77#b77;,b77iv71 and cease making purchases under such program and representing to third parties that it may purchase under such program4 ,such an entity may seek to register under another covered entity category described in paragraph 7#d7 if such entity meets the criteria for such a category and applicable requirements under this section4 7,e7 ,obligation to self-disclose ,a covered entity described in subparagraph 7,d7 shall immediately disclose to the ,secretary and the manufacturer of the affected covered outpatient drug any purchase made under the program under this section by such covered entity that1 at the time of the purchase of such drug1 did not fully satisfy the requirements in subparagraphs 7,b7 and 7,c74 ,any such purchase shall require the covered entity to promptly conduct an audit supervised by the ,secretary to identify the full scope of noncompliance with such requirements and to provide the written results of such audit to the ,secretary and the manufacturer of the affected covered outpatient drug4 ,the covered entity shall be liable to the manufacturer of the covered outpatient drug that is the subject of the noncompliance in an amount equal to the reduction in the price of the drugs provided under paragraph 7#a71 plus interest on such amount1 which shall be compounded monthly and equal to the current short-term interest rate as determined by the ,federal ,reserve for the time period for which the covered entity is liable4 7,f7 ,civil monetary penalty ,where a covered entity fails to satisfy a requirement in subparagraph 7,d7 or 7,e71 the covered entity shall be required to pay a civil monetary penalty equal to #b1ejj for each violation1 which amount shall be adjusted for inflation annually to reflect the rate of change in the ,consumer ,price ,index for ,all ,urban ,consumers published by the ,bureau of ,labor ,statistics4 ,the provisions of section #aabh;,a of the ,social ,security ,act 7other than subsections 7a7 and 7b77 shall apply to a civil monetary penalty under this subparagraph in the same manner as such provisions apply to a penalty or proceeding under section #aabh;,a7a74 ,the ,office of ,inspector ,general of the ,department of ,health and ,human ,services shall carry out the provisions related to the imposition of civil monetary penalties under this subparagraph4 7#ac7 ,prohibition against extraordinary collection actions 7,a7 ,e,c,as prohibited ,a covered entity described in subparagraphs 7,l7 through 7,o7 of paragraph 7#d7 is prohibited from engaging in extraordinary collection actions 7,e,c,as71 as such term is described in section #eja7r77#f7 of the ,internal ,revenue ,code and its implementing regulations set forth in section #a4eja7r7-#f of title #bf of the ,code of ,federal ,regulations 7or any successor regulations71 with respect to health care items and services furnished to uninsured individuals or low-income individuals4 7,b7 ,audits ,the ,secretary shall audit for covered entity compliance with this paragraph1 establish a process for individuals to report suspected violations of this paragraph to the ,secretary1 and promptly and fully investigate such reports of suspected violations4 7,c7 ,civil monetary penalty ,where a covered entity violates the prohibition in this paragraph1 the covered entity shall be required to pay a civil monetary penalty equal to #b1ejj for each extraordinary collection action taken with respect to an individual described in this paragraph1 which amount shall be adjusted for inflation annually to reflect the rate of change in the ,consumer ,price ,index for ,all ,urban ,consumers published by the ,bureau of ,labor ,statistics4 ,the provisions of section #aabh;,a of the ,social ,security ,act 7other than subsections 7a7 and 7b77 shall apply to a civil monetary penalty under this paragraph in the same manner as such provisions apply to a penalty or proceeding under section #aabh;,a7a74 ,the ,office of ,inspector ,general of the ,department of ,health and ,human ,services shall carry out the provisions related to the imposition of civil monetary penalties under this paragraph4 7,d7 ,definitions ,in this paragraph1 the terms low-income individual and uninsured have the meanings given such terms in paragraph 7#aa74 7#ad7 ,additional requirement for certain hospitals 7,a7 ,in general ,during the first calendar year beginning on or after the date that is #bd months after the date of enactment of this paragraph and during each subsequent calendar year1 a covered entity described in paragraph 7#d77,l7 shall determine by ,october #a of each such year1 based on the most recent year of data it has reported to the ,secretary under paragraph 7#e77,l7 at that point in time1 whether the annual charity care costs it incurred for the year reported were greater than or equal to the margin it realized under the program under this section for that same year4 ,as described further in subparagraph 7,d71 for the period specified in the preceding sentence1 having annual charity care costs that equal or exceed the margin for the most recently reported year is a condition of such covered entity's participation in the program under this section for the upcoming calendar year1 and failure to meet this condition shall require deregistration and self-disclosure using the procedures described in subparagraphs 7,d7 and 7,e74 ,such covered entity shall be subject to a civil monetary penalty described in subparagraph 7,f7 for failure to deregister and self-disclose in accordance with the preceding sentence4 7,b7 ,annual charity care costs ,the term annual charity care costs means the total costs incurred during the year by the covered entity and its child sites 7as defined in paragraph 7#e77;,e77i77 for charity care 7as defined in line #bc of worksheet ,s-#aj to the ,medicare cost report1 or in any successor form74 7,c7 ,margin ,the term margin means the margin reported by the covered entity for the year pursuant to paragraph 7#e77,l77i77,v74 7,d7 ,deregistration and conditions for subsequent registration 7i7 ,de-registration ,on ,october #a of each year beginning on or after the date that is #bd months after the date of enactment of this paragraph1 each covered entity subject to this paragraph that has reported at least one year of data to the ,secretary under paragraph 7#e77,l7 and that does not have1 for the most recently reported year1 annual charity care costs greater than or equal to the margin1 shall notify the ,secretary that it does not meet the condition of participation under this paragraph for the upcoming calendar year1 deregister the entity from the program under this section and the identification system described in subsection 7d77#b77;,b77iv7 for the upcoming calendar year1 cease making purchases under such program as of the start of the upcoming calendar year1 cease representing to third parties that it may purchase under such program beyond the current calendar year1 and refrain from purchasing covered outpatient drugs under this section in quantities exceeding such entity's bona fide needs for the remainder of the current calendar year4 7ii7 ,registration following de-registration 7,i7 ,registration under another covered entity category ,a covered entity that must deregister under this subparagraph shall not be prohibited from registering to participate in the program under this section under another covered entity category described in paragraph 7#d7 if such entity meets the criteria for such a category and applicable requirements under this section4 7,,ii7 ,registration under paragraph 7#d77,l7 ,in order to register under paragraph 7#d77,l71 a hospital that has been required to deregister under this subparagraph must demonstrate to the ,secretary 7in a form and manner specified by the ,secretary1 and in addition to demonstrating that it satisfies the other applicable registration criteria under paragraph 7#d77,l77 that its annual charity care cost 7as defined in subparagraph 7,b77 for the most recent year that the hospital would have reported under paragraph 7#d77,l7 absent the deregistration exceeded by at least one percent point the annual charity care cost for the year preceding deregistration by the hospital4 ,if the hospital is found to meet this requirement and approved by the ,secretary for registration under paragraph 7#d77,l71 then the hospital will be required to resume reporting under paragraph 7#e77,l7 and 7once the entity has reported at least one year of data to the ,secretary under paragraph 7#e77,l77 to meet the condition of participation described in this paragraph for the most recently reported year as of ,october #a of each year4 7,e7 ,obligation to self-disclose ,a covered entity described in subparagraph 7,d7 shall immediately disclose to the ,secretary and the manufacturer of the affected covered outpatient drug any purchase it made under this section during a calendar year in which it was ineligible to participate in the program under this section4 ,any such purchase shall require the covered entity promptly to conduct an audit supervised by the ,secretary to identify the full scope of noncompliance and to provide the written results of such audit to the ,secretary and the manufacturer of the affected covered outpatient drug4 ,the covered entity shall be liable to the manufacturer of the covered outpatient drug that is the subject of the noncompliance in an amount equal to the reduction in the price of the drugs provided under paragraph 7#a71 plus interest on such amount1 which shall be compounded monthly and equal to the current short-term interest rate as determined by the ,federal ,reserve for the time period for which the covered entity is liable4 7,f7 ,civil monetary penalty ,where a covered entity fails to satisfy a requirement in subparagraph 7,d7 or 7,e71 the covered entity shall be required to pay a civil monetary penalty equal to #b1ejj for each violation1 which amount shall be adjusted for inflation annually to reflect the rate of change in the ,consumer ,price ,index for ,all ,urban ,consumers published by the ,bureau of ,labor ,statistics4 ,the provisions of section #aabh;,a of the ,social ,security ,act 7other than subsections 7a7 and 7b77 shall apply to a civil monetary penalty under this subparagraph in the same manner as such provisions apply to a penalty or proceeding under section #aabh;,a7a74 ,the ,office of ,inspector ,general of the ,department of ,health and ,human ,services shall carry out the provisions related to the imposition of civil monetary penalties under this subparagraph4 4 #ac4 #cdj;,b program ,section #cdj;,b7a7 of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bef;b7a77 is further amended by adding at the end the following3 7#ae7 #cdj;,b program ,the intent of this section is to provide for manufacturer price reductions that enable covered entities1 whose mission is to serve underserved or otherwise vulnerable communities1 to increase access to affordable drugs and health services for these communities4 4 #ad4 ,audits of private nonhospital contracts with ,state and local governments ,section #cdj;,b7d77#b77;,b7 of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bef;b7d77#b77;,b77 is amended by adding at the end the following3 7vi7 ,the conducting of annual audits by the ,secretary of contracts between a covered entity described in subparagraph 7,l7 or subparagraph 7,m7 of subsection 7a77#d71 or subparagraph 7,o7 of such subsection with respect to a rural referral center1 that is a private nonprofit hospital subject to the requirements in subsections 7a77#d77,l77i7 and 7a77#aa7 and a ,state or local government for at least #aj percent of all such entities participating in the program under this section4 ,the ,secretary shall develop and publicly disclose standards used to determine whether such contracts satisfy the applicable requirements described in subsections 7a77#d77,l77i7 and 7a77#aa7 and publicly disclose the findings from such audits4 ,the ,secretary shall remove from the program under this section any such entity that does not have a contract in effect with a ,state or local government that satisfies the applicable requirements set forth in subsections 7a77#d77,l77i7 and 7a77#aa71 and such removal shall require such covered entity to promptly conduct an audit supervised by the ,secretary to identify discounts on covered outpatient drugs purchased at a discount under this section to which such covered entity was not eligible and provide the written results of such audit to the ,secretary and the manufacturer of the affected covered outpatient drug4 ,such covered entity shall be liable to the manufacturer of such covered outpatient drug in an amount equal to the reduction in the price of the drugs provided under subsection 7a77#a71 plus interest on such amount1 which shall be compounded monthly and equal to the current short-term interest rate as determined by the ,federal ,reserve for the time period for which the covered entity is liable4 ,where a covered entity described in this clause knowingly and intentionally violates a requirement in subsection 7a77#d77,l77i7 or 7a77#aa71 the covered entity shall be required to pay a civil monetary penalty equal to #a1jjj for each claim for a covered outpatient drug that is subject to the violation1 which amount shall be adjusted for inflation annually to reflect the rate of change in the ,consumer ,price ,index for ,all ,urban ,consumers published by the ,bureau of ,labor ,statistics4 ,the provisions of section #aabh;,a of the ,social ,security ,act 7other than subsections 7a7 and 7b77 shall apply to a civil monetary penalty under this clause in the same manner as such provisions apply to a penalty or proceeding under section #aabh;,a7a74 ,the ,office of ,inspector ,general of the ,department of ,health and ,human ,services shall carry out the provisions related to the imposition of civil monetary penalties under this clause4 4 #ae4 ,ensuring covered entity compliance with transparency requirements ,section #cdj;,b7d77#b77;,b7 of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bef;b7d77#b77;,b77 is further amended by adding at the end the following3 7vii7 ,the imposition of civil monetary penalties in amounts determined appropriate by the ,secretary in the case that the ,secretary determines that a covered entity is not in compliance with subsection 7a77#e77,l74 4 #af4 #cdj;,b claims data clearinghouse 7a7 #cdj;,b claims data clearinghouse ,section #cdj;,b7d77#b7 of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bef;b7d77#b77 is amended by adding at the end the following3 7,c7 #cdj;,b claims data clearinghouse 7i7 ,in general ,the improvements described in subparagraph 7,a7 shall include the establishment of a claims data clearinghouse described in this subparagraph4 ,not later than one year after the date of enactment of this subparagraph1 the ,secretary shall enter into a contract with a third-party entity that meets the criteria specified in clause 7ii7 7such entity is hereinafter referred to as the clearinghouse7 for purposes of-- 7,i7 identifying claims for covered outpatient drugs purchased under the program under this section for which reimbursement was made under a ,state plan 7or waiver of such plan7 and ensuring such claims are or were not included in any ,state rebate request under section #aibg of the ,social ,security ,act in violation of sections #aijc7m77#b77;,a77xiii7 or #aibg7;j77#a7 of such ,act or section #cdj;,b7a77#e77;,a7 of this ,act2 7,,ii7 identifying claims for covered outpatient drugs purchased under the program under this section that are selected drugs 7as defined in section #aaib7;c7 of the ,social ,security ,act7 and ensuring that1 for each such claim1 the nonduplication requirements of section #aaic7;d7 of such ,act have been met2 7,,iii7 identifying claims for covered outpatient drugs purchased under the program under this section that are either ,part ,b rebatable drugs or ,part ,d rebatable drugs and providing all relevant information regarding such claims to the ,secretary to ensure that claims that are subject to a discount under the program under this section are excluded from inflation rebate calculations pursuant to section #ahdg;,a7i77#c77;,b77ii77,i7 of the ,social ,security ,act 7with respect to ,part ,b rebatable drugs7 and section #ahfj;,d-#ad;,b7b77#a77;,b7 of such ,act 7with respect to ,part ,d rebatable drugs72 7,,iv7 identifying duplicate claims for a rebate or discount submitted by two or more covered entities 7or an entity or entities acting on their behalf7 with respect to the same unit of a covered outpatient drug purchased under the program under this section and implementing a process to ensure a manufacturer of such a drug does not pay more than one rebate or discount under this section with respect to such unit2 and 7,v7 providing to manufacturers of covered outpatient drugs1 in a form and manner specified by the ,secretary in consultation with manufacturers1 access to the data described in subsection 7a77#e77;,j7 with respect to each dispense or administration of a manufacturer's covered outpatient drugs for which a covered entity receives a discount under this section4 7ii7 ,criteria for clearinghouse ,the criteria described in this clause include the following3 7,i7 ,the clearinghouse shall not be owned by1 overseen by1 or affiliated with a covered entity described in subsection 7a77#d7 and shall not currently be a party to a contractual arrangement with the ,health ,resources and ,services ,administration4 7,,ii7 ,the clearinghouse shall have demonstrated experience adjudicating claims for health care items and services in real time for self- and provider-administered drugs and working with protected health information and confidential pricing information4 7,,iii7 ,the clearinghouse shall agree to confidentiality obligations that prohibit the clearinghouse from using information it receives under this subparagraph for any purpose other than a purpose set forth in this subparagraph1 or disclosing such information to any individual or entity other than the ,secretary1 provided the ,secretary shall not use such information for purposes of making reimbursement or coverage determinations1 or a manufacturer in accordance with this subparagraph 7and only with respect to such manufacturer's covered outpatient drugs74 7,,iv7 ,the clearinghouse shall maintain the security of the data reported pursuant to this subsection 7a77#e77;,j7 in a manner consistent with the ,,hipaa ,security ,standards set forth in sections #afd4cjd-afd4cab and #afd4caf of title #de1 ,code of ,federal ,regulations 7or any successor regulations71 as if the clearinghouse were subject to those standards as a ,,hipaa covered entity4 7iii7 ,duties of clearinghouse ,the clearinghouse shall-- 7,i7 review claims level data for covered outpatient drugs described in subsection 7a77#e77;,j7 submitted by covered entities in accordance with such subsection2 7,,ii7 review claims level data1 including rebate file data1 submitted to the clearinghouse by ,state agencies and ,medicaid managed care organizations for covered outpatient drugs subject to an agreement under this section dispensed or administered to individuals enrolled under a ,state plan 7or a waiver of such plan7 and claims level data submitted by ,medicare ,administrative ,contractors1 ,medicare ,advantage organizations 7including ,medicare ,advantage ,organizations offering an ,,ma-,,pd plan71 and ,,pdp sponsors for covered outpatient drugs subject to an agreement under this section dispensed or administered to individuals enrolled under ,part ,b1 ,part ,c1 or ,part ,d of title ,,xviii of the ,social ,security ,act2 7,,iii7 within #e days of identification1 provide written notice of a duplicate discount or rebate to the ,state agency1 the ,secretary1 the covered entity1 and the affected drug manufacturer itemizing any violation described in clause 7i77,i72 7,,iv7 within #e days of identification1 provide written notice to the ,secretary1 the covered entity 7or entities1 as applicable71 and the affected drug manufacturer itemizing any violation described in subclauses 7,,ii7 or 7,,iv7 of clause 7i72 7,v7 have access to the internet website described in paragraph 7#a77;,b77iii7 containing applicable ceiling prices for covered outpatient drugs for purposes of identifying violations described in clause 7i77,,ii72 7,,vi7 subject to clauses 7i77,v7 and 7ii77,,iii71 make the data described in subclauses 7,i7 and 7,,ii7 available to the manufacturer in electronic format not later than #aj days after such data is provided to the clearinghouse2 7,,vii7 upon request by the ,centers for ,medicare ,medicaid ,services1 make the data described in subclauses 7,i7 and 7,,ii7 available for purposes of excluding #cdj;,b purchased units of ,part ,b rebatable drugs or ,part ,d rebatable drugs from ,part ,b or ,part ,d inflation rebates pursuant to section #ahdg;,a7i77#c77;,b77ii77,i7 or section #ahfj;,d-#ad;,b7b77#a77;,b7 of the ,social ,security ,act2 and 7,,viii7 identify claims for covered outpatient drugs subject to an agreement under this section that are submitted by pharmacies removed from the #cdj;,b program pursuant to subsection 7a77#e77;,f77ix77,,iii7 and notify the ,secretary of the submission of any such claims by any such pharmacies4 7iv7 ,resolution of violations 7,i7 ,medicaid duplicate discounts ,the ,secretary1 in consultation with the ,state1 as appropriate1 shall take prompt action to fairly and adequately resolve violations described in clause 7i77,i7 reported by the clearinghouse in accordance with clause 7iii77,,iii74 7,,ii7 ,nonduplication with maximum fair price ,the ,secretary shall take prompt action to fairly and adequately resolve violations described in clause 7i77,,ii7 reported by the clearinghouse in accordance with clause 7iii77,,iv74 7,,iii7 ,duplicate covered entity discounts ,the ,secretary shall develop and implement a process to resolve duplicate claims for a rebate or discount under this section described in clause 7i77,,iv7 such that the manufacturer pays only one rebate or discount under this section with respect to the same unit of a covered outpatient drug purchased under the program under this section4 ,covered entities 7and any entities acting on their behalf7 shall be subject to determinations made by the ,secretary to resolve such duplicate claims 7and the ,secretary may contract this function to the clearinghouse to make such determinations74 ,in making such determinations1 the ,secretary shall investigate duplicate claims for rebates or discounts and require covered entities 7and any entities acting on their behalf7 to take action to avoid or pay refunds to reverse a duplicate claim4 7,,iv7 ,refunds to manufacturers ,the ,secretary shall be responsible for promptly refunding affected manufacturers of covered outpatient drugs for violations described in subclauses 7,i7 and 7,,ii7 of clause 7i7 and seeking subsequent repayment from covered entities or ,states 7with respect to violations described in clause 7i77,i771 or providers or dispensers 7with respect to violations described in clause 7i77,,ii774 ,subject to the determination by the ,secretary or clearinghouse under subclause 7,,iii71 the covered entity 7or entities7 shall be liable to the manufacturer of the covered outpatient drug that is the subject of the violation described in clause 7i77,,iv7 in an amount equal to the reduction in the price of the drug 7as described in subsection 7a77#a77 and shall repay such amount to such manufacturer within #fj days of receiving a notice described in clause 7iii77,,iv74 4 7b7 ,provision of drug claims data by medicaid2 removal of duplicate claims 7#a7 ,medicaid ,section #aijb7;a7 of the ,social ,security ,act 7#db ,u4,s4,c4 #acif;a7a77 is amended-- 7,a7 in paragraph 7#hf71 by striking and at the end2 7,b7 in paragraph 7#hg77;,d71 by striking the period and inserting 2 and2 and 7,c7 by inserting after paragraph 7#hg7 the following new paragraph3 7#hh7 provide for a mechanism for the ,state agency to furnish1 and for the ,state agency to require each ,medicaid managed care organization 7as defined in section #aijc7m77#a77;,a77 to furnish1 to the clearinghouse1 in a machine-readable format1 within #e days following the date of claim payment1 claims level data1 including rebate file data1 for covered outpatient drugs dispensed1 furnished1 or administered to individuals enrolled under a ,state plan 7or a waiver of such plan7 that includes1 with respect to each dispense1 furnishing1 or administration of such a drug1 the data elements described in subsection #cdj;,b7a77#e77;,j77iii7 of the ,public ,health ,service ,act1 and for the ,state agency to remove from any rebate request described in section #cdj;,b7d77#b77;,c77i77,i7 of such ,act any claim that is the subject of a notice submitted by such entity under section #cdj;,b7d77#b77;,c77iii77,,iii7 of such ,act4 4 7c7 ,provision of drug claims data by ,medicare 7#a7 ,medicare ,part ,b ,section #ahdb of the ,social ,security ,act 7#db ,u4,s4,c4 #acieu7 is amended by adding at the end the following3 7v7 ,provision of drug claims data2 mechanism ,to refund duplicated amounts ,each ,medicare administrative contractor shall furnish to the clearinghouse1 in a machine-readable format1 claims level data for covered outpatient drugs furnished or administered to individuals enrolled under this part that includes1 with respect to each furnishing or administration of such a drug1 the data elements described in section #cdj;,b7a77#e77;,j77iii7 of the ,public ,health ,service ,act4 ,each ,medicare administrative contractor shall furnish such data to the clearinghouse within #e days following the date the claim for such drug is paid by the ,medicare administrative contractor4 4 7#b7 ,medicare ,advantage organizations ,section #aheg7;e7 of the ,social ,security ,act 7#db ,u4,s4,c4 #aciew-#bg7;e77 is amended by adding at the end the following3 7#f7 ,provision of drug claims data2 mechanism to refund duplicated amounts ,a contract under this part shall require a ,medicare,choice organization to furnish to the clearinghouse1 in a machine-readable format1 claims level data for covered outpatient drugs furnished or administered to individuals enrolled with the organization under this part that includes1 with respect to each furnishing or administration of such a drug1 the data elements described in section #cdj;,b7a77#e77;,j77iii7 of the ,public ,health ,service ,act4 ,such contract shall require the ,medicare,choice organization to furnish such data to the clearinghouse within #e days following the date the claim for such drug is paid by the ,medicare,choice organization4 4 7#c7 ,prescription drug plans ,section #ahfj;,d-#ab7;b7 of the ,social ,security ,act 7#db ,u4,s4,c4 #aciew-#aab7;b77 is amended by adding at the end the following3 7#i7 ,provision of drug claims data2 mechanism to refund duplicated amounts ,a contract under this part shall require a ,,pdp sponsor to furnish to the clearinghouse in a machine-readable format1 claims level data for covered outpatient drugs dispensed to individuals enrolled in a prescription drug plan offered by such sponsor under this part that includes1 with respect to each dispense of such drug1 the data elements described in section #cdj;,b7a77#e77;,j77iii7 of the ,public ,health ,service ,act4 ,such contract shall require a ,,pdp sponsor to furnish such data to the clearinghouse within #e days following the date the claim for such drug is paid by the ,,pdp sponsor4 4 7#d7 ,,ma-,p,ds ,section #aheg7;f77#c7 of the ,social ,security ,act 7#db ,u4,s4,c4 #aciew-#bg7;f77#c77 is amended by adding at the end the following3 7,f7 ,provision of drug claims data2 mechanism to refund duplicated amounts ,section #ahfj;,d-#ab7;b77#i74 4 #ag4 ,limitation on administrator service fees and contract pharmacy fees ,section #cdj;,b of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bef;b7 is amended by adding at the end the following3 7f7 ,requirements for ,,tpa and contract pharmacy remuneration 7#a7 ,third-party administrator fees ,a third-party administrator furnishing #cdj;,b program-related services on behalf of a covered entity described in subsection 7a77#d71 including reviewing or processing claims or other information to identify covered outpatient drugs dispensed to individuals who are patients of the covered entity 7as defined in subsection 7b77#c77 may receive remuneration from such covered entity for the performance of such services only if-- 7,a7 such remuneration is a flat dollar amount not directly or indirectly based on any price of1 or discount or other remuneration provided with respect to1 a covered outpatient drug1 paid for each unit of service furnished to the covered entity1 regardless of whether a prescription was dispensed to an individual who is a patient of the covered entity2 7,b7 the amount of such remuneration is consistent with fair market value in an arm's-length transaction for the bona fide1 itemized #cdj;,b-related services actually performed on behalf of the covered entity2 and 7,c7 such remuneration complies with applicable ,state and ,federal law1 including section #aabh;,b7b7 of the ,social ,security ,act4 7#b7 ,contract pharmacy fees ,a contract pharmacy that has entered into a written agreement with a covered entity pursuant to and satisfies the applicable requirements in subsection 7a77#e77;,f7 may receive remuneration from such covered entity for the performance of services associated with dispensing covered outpatient drugs subject to an agreement under this section to individuals who are patients of the covered entity 7as defined in subsection 7b77#c77 only if-- 7,a7 such remuneration is a flat dollar amount not directly or indirectly based on any price of1 or discount or other remuneration provided with respect to1 a covered outpatient drug1 paid for each dispense of such a drug to a patient of the covered entity2 7,b7 the amount of remuneration for each dispense does not exceed #abe percent of the average per-prescription dispensing fee paid to such pharmacy by all third-party payors1 based on data from the most recent full calendar year for which such data is available2 7,c7 the amount of such remuneration is consistent with fair market value in an arm's-length transaction for the bona fide1 itemized #cdj;,b-related services actually performed on behalf of the covered entity2 and 7,d7 such remuneration complies with applicable ,state and ,federal law1 including section #aabh;,b7b7 of the ,social ,security ,act4 ,for purposes of subparagraph 7,b71 if a covered entity has entered into an agreement for contract pharmacy services pursuant to subsection 7a77#e77;,f7 that permits the contract pharmacy service provider to dispense covered outpatient drugs on behalf of the covered entity at more than one pharmacy location1 the average dispensing fee shall be calculated across all pharmacy locations subject to such agreement4 7#c7 ,auditable records ,a covered entity shall retain copies of written agreements with third-party administrators or contract pharmacies described in this subsection for a period of time specified by the ,secretary and shall make copies of such agreements available to the ,secretary or their designee upon request4 7#d7 ,civil monetary penalty ,a third-party administrator or contract pharmacy described in this subsection that fails to comply with the applicable requirements specified in this subsection shall be required to pay a civil monetary penalty equal to #aj times the amount such third-party administrator or contract pharmacy received for the performance of relevant services described in this subsection4 ,the provisions of section #aabh;,a of the ,social ,security ,act 7other than subsections 7a7 and 7b77 shall apply to a civil monetary penalty under this paragraph in the same manner as such provisions apply to a penalty or proceeding under section #aabh;,a7a74 ,the ,office of ,inspector ,general of the ,department of ,health and ,human ,services shall carry out the provisions related to the imposition of civil monetary penalties under this paragraph4 4 #ah4 ,clarification ,section #cdj;,b of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bef;b7 is further amended by adding at the end the following3 7g7 ,clarification ,the provisions of this section supersede any provision or requirement of ,state or local law insofar as that ,state or local law may establish1 implement1 or continue in effect a standard or requirement that differs from or relates in any way to the provisions of this section or1 except for any ,state regulations issued to carry out subsection 7a77#e77;,a77iii71 relates in any way to the drug discount program under this section or covered outpatient drugs subject to an agreement under this section1 including the distribution of such drugs4 ,except for any ,state regulations issued to carry out subsection 7a77#e77;,a77iii71 no provision or requirement of ,state or local law shall grant additional rights or impose additional obligations related to the #cdj;,b program4 4 #ai4 ,ensuring the equitable treatment of #cdj;,b covered entities and pharmacies participating in the #cdj;,b drug discount program 7a7 ,group health plan and health insurance issuer requirements ,subpart ,,ii of part ,a of title ,,xxvii of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #cjj;gg-#aa et seq47 is amended by adding at the end the following3 #bgcj4 ,requirements relating to the #cdj;,b drug discount program 7a7 ,in general ,a group health plan1 a health insurance issuer offering group or individual health insurance coverage1 or a pharmacy benefit manager acting on behalf of such plan or issuer1 may not discriminate against a covered entity 7as defined in subsection 7e77#a771 a contract pharmacy 7as defined in subsection 7e77#b771 or a participant1 beneficiary1 or enrollee of such plan or coverage by imposing requirements1 exclusions1 reimbursement terms1 or other conditions on such entity or pharmacy that differ from those applied to entities or pharmacies that are not covered entities or contract pharmacies on the basis that the entity or pharmacy is a covered entity or contract pharmacy or that the entity or pharmacy dispenses #cdj;,b drugs1 by taking any action prohibited under subsection 7b74 7b7 ,specified prohibited actions ,a group health plan1 a health insurance issuer offering group or individual health insurance coverage1 or a pharmacy benefit manager acting on behalf of such plan or issuer1 may not discriminate against a covered entity1 a contract pharmacy1 or a participant1 beneficiary1 or enrollee of such plan or coverage by doing any of the following3 7#a7 ,reimbursing a covered entity or contract pharmacy for a quantity of a #cdj;,b drug 7as defined in subsection 7e77 in an amount less than such plan1 issuer1 or pharmacy benefit manager 7as applicable7 would pay to any other similarly situated 7as specified by the ,secretary7 entity or pharmacy that is not a covered entity or a contract pharmacy for such quantity of such drug on the basis that the entity or pharmacy is a covered entity or contract pharmacy or that the entity or pharmacy dispenses #cdj;,b drugs4 7#b7 ,imposing any terms or conditions on covered entities or contract pharmacies with respect to any of the following that differ from such terms or conditions applied to other similarly situated entities or pharmacies that are not covered entities or contract pharmacies on the basis that the entity or pharmacy is a covered entity or contract pharmacy or that the entity or pharmacy dispenses #cdj;,b drugs3 7,a7 ,fees1 chargebacks1 clawbacks1 adjustments1 or other assessments4 7,b7 ,professional dispensing fees4 7,c7 ,restrictions or requirements regarding participation in standard or preferred pharmacy networks4 7,d7 ,requirements relating to the frequency or scope of audits or to inventory management systems using generally accepted accounting principles4 7,e7 ,any other restrictions1 conditions1 practices1 or policies that interfere with the ability of a covered entity or contract pharmacy to use the discounts provided under section #cdj;,b in accordance with applicable requirements under such section4 7#c7 ,interfering with an individual's choice to receive a #cdj;,b drug from a covered entity or contract pharmacy1 whether in person or via direct delivery1 mail1 or other form of shipment1 as permitted under section #cdj;,b4 7#d7 ,interfering with1 limiting1 or prohibiting actions by a covered entity or contract pharmacy to identify1 either directly or through a third party1 claims for #cdj;,b drugs1 including by submission of claims data or use of claims modifiers or indicators4 7#e7 ,refusing to contract with a covered entity or contract pharmacy for reasons other than those that apply equally to entities or pharmacies that are not covered entities or contract pharmacies1 or on the basis that-- 7,a7 the entity or pharmacy is a covered entity or a contract pharmacy2 or 7,b7 the entity or pharmacy is described in any of subparagraphs 7,a7 through 7,o7 of section #cdj;,b7a77#d74 7#f7 ,with respect to a group health plan or health insurance issuer for health insurance coverage1 denying coverage of a drug on the basis that such drug is a #cdj;,b drug4 7c7 ,prohibited actions in derogation of section #cdj;,b affordability assistance provisions ,a group health plan1 a health insurance issuer offering group or individual health insurance coverage1 or a pharmacy benefit manager acting on behalf of such plan or issuer shall not prohibit or restrict1 in contracts with pharmacies in their network that are contract pharmacies or entity pharmacies1 or in any other manner1 any reduction in or subsidy for the out-of-pocket amount for a #cdj;,b drug charged to an individual 7including a participant1 beneficiary1 or enrollee of such plan or coverage7 that is required or authorized by subparagraphs 7,g7 or 7,h7 of section #cdj;,b7a77#e74 ,any general prohibition or restriction on reducing or subsidizing the out-of-pocket amount for a drug charged to an individual that lacks an express exemption for any reductions in or subsidies for the out-of-pocket amount for a #cdj;,b drug that are required or authorized by subparagraphs 7,g7 or 7,h7 of section #cdj;,b7a77#e7 is a violation of this subsection4 ,any contractual provision that violates this subsection in any manner shall be void and unenforceable4 7d7 ,enforcement mechanism for pharmacy benefit managers ,the ,secretary shall impose a civil monetary penalty on any pharmacy benefit manager that violates the requirements of this section4 ,such penalty shall not exceed #e1jjj per violation per day4 ,the ,secretary shall issue proposed regulations to implement this subsection not later than #fj days after the date of the enactment of this subsection and shall finalize such regulations not later than #ahj days after such date of enactment4 7e7 ,definitions ,for purposes of this section3 7#a7 #cdj;b drug ,the term #cdj;,b drug means a drug that is-- 7,a7 a covered outpatient drug 7as defined for purposes of section #cdj;,b72 and 7,b7 purchased under an agreement in effect under such section4 7#b7 ,contract pharmacy ,the term contract pharmacy has the meaning given such term in section #cdj;,b7a77#e77;,f74 7#c7 ,covered entity ,the term covered entity has the meaning given such term in section #cdj;,b7a77#d74 7#d7 ,entity pharmacy ,the term entity pharmacy has the meaning given such term in section #cdj;,b7a77#e77;,f74 4 7b7 ,application of requirements to ,medicare 7#a7 ,part ,d ,section #ahfj;,d-#ab7;b7 of the ,social ,security ,act 7#db ,u4,s4,c4 #aciew-#aab7;b77 is amended by adding at the end the following3 7#aj7 ,application of requirements relating to the #cdj;,b drug discount program ,each contract entered into under this subsection with a ,,pdp sponsor shall provide that the requirements of section #bgcj of the ,public ,health ,service ,act apply to such sponsor1 and to any pharmacy benefit manager that contracts with such sponsor1 in the same manner as such requirements apply with respect to a group health plan1 a health insurance issuer1 or a pharmacy benefit manager described in such section4 4 7#b7 ,part ,c ,section #aheg7;f77#c7 of the ,social ,security ,act 7#db ,u4,s4,c4 #aciew-#bg7;f77#c77 is amended by adding at the end the following3 7,g7 #cdj;,b drug discount program ,section #ahfj;,d-#ab7;b77#aj74 4 #bj4 ,effective date ,except as otherwise specified1 the provisions in this ,act shall become effective on the date that is one year following the date of enactment of this ,act4